South American Gold has assembled a nice portfolio of gold and silver exploration interests, both at home here in the U.S. with their New Light Mine gold-silver project up in northern Washington State, the Baltimore Silver project in Montana, the newer Kelly Project group of mining claims in western Montana, and the GB-2 mining claims in Arizona, as well as abroad in Colombia via the Narino Department in the south and the Santacruz Gold project. Today the company was pleased to offer markets a sweeping update on their 2013 activities and developments.
The company is hard at work vetting existing interests, establishing exploration vectors where appropriate or holding/disposing of mineral property interests, all while continually scouting for new potential acquisitions. Spurred on by recent positive results at their GB-2 claims, as well as at the Baltimore Silver Mine project, which was expanded by 40 acres at the end of last year (Aug 23, 2012), SAGD is rigorously prioritizing right now and going over at the permitting end of things at GB-2 and Baltimore.
Furthermore, SAGD is openly seeking JV options for their projects and they are confident that potential JV partners will be as pleased with the progress the company has made as is SAGD’s management. The market is obviously ridiculous right now for junior miners and exploration is dicey at best, so it takes good deposits, share structure, and personnel to bring investors to the table, and SAGD is shopping various financing alternatives around right now to beef up their working capital position even more. The second half of this year should see improved buzz generation from the company as they reach out for market awareness and leverage their strong position to generate business development traction that will lead to cash flow and/or assets that will further improve shareholder position. SAGD isn’t fooling around either and they openly invite shareholder inquiry as well as review of their relevant filings.
Looking at the details disclosed in today’s report we see that the Baltimore Silver Mine project is doing quite well, with recent activities having culminated in comprehensive sampling of extant tailings and dump material, producing results in line with projections that place Baltimore near the head of the pack as a potential silver producer. Mining here stretches back to the nineteenth century and SAGD is very bullish, pegging a local mining engineer to handle the permit application builds and laying out the budgetary leeway for a rehabilitation of tunnels to get at the underground workings, as well as allow for a more detailed sampling.
GB-2 is the other really strong lead among the company’s projects. Again, as with Baltimore, we have extensive historic mining, here on a district scale and with on-site breccia pipes and other sweet geology, as well as geologic evaluations in-hand that have helped create a clear target map for quantifying grade extent and depths. The next step at GB-2 is setting out their data into a more refined plan of operations for approval, but this should go smoothly, as they have essentially confirmed the legitimacy of their plan already via the evaluations.
The Kelly Project group of mining claims looks good and the company has slated surface sampling for this year, as well as an in-depth review of the existing adits, with a mind towards resolving a more complete channel sampling program in the immediate future. Small scale production looks doable here and SAGD is currently going over the potential budgets and permitting requirements, including whether or not previously granted SME exploration approval will work for one part of the site.
The New Light Mine project has seen delayed activity on account of the bad weather conditions up in northern WA, but the company is looking at expanding their position here this summer and has put together a small plan for additional explorative efforts.
For more information on South American Gold, visit www.SAGoldCorp.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Friday, June 28, 2013
TeleCommunication Systems Inc. (TSYS) Video Chart for Friday, June 28, 2013
2013 TSYS has made a strong move over the past week to rise about 20 percent to face a resistance point at $2.40. Should the pps break the resistance, which will keep it over the 50-day and 200-day moving averages, there is not much resistance until old highs at $2.70.
To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
VentriPoint Diagnostics Ltd. (VPTDF) Offers Superior Solution to Right Heart Analysis
VentriPoint Diagnostics is a Seattle-based provider of a superior heart analysis system. The VentriPoint technology uses conventional 2-dimensional ultrasound data, plus a patented system for analyzing the data called Knowledge-Based Reconstruction (KBR). The result is a 3-dimensional model of the heart, providing critical information regarding things like heart volumes and cardiac output.
The VentriPoint system, called Angelo, is of special value for doing what is called right-heart analysis, where the physician needs a clear view of the portion of the heart that pumps blood to the lungs for oxygenation. It is normally difficult to image the right heart using ultrasound, due to the obstruction of the ribs. As a result, physicians often use MRI imaging to get the necessary detail, even though MRI imaging costs more and is more difficult for the patient, especially for children. The VentriPoint system provides the needed heart information without requiring an MRI, but rather with easy-to-use and far less expensive ultrasound technology. It removes the need to sedate children and for second visits.
The VentriPoint system has key applications for congenital heart disease and pulmonary arterial hypertension, and is being researched for a number of other applications:
• Single ventricle
• Perimount (R) Valves
• Ebsteins
• Workflow analysis
• Economic analysis
• RV to PA conduit
• Left ventricle
• Heart failure
• Coronary artery disease
The system has already been installed in major cardiac centers in Canada, Europe, and North America, and has also been the subject of scientific publications in major heart journals.
For more information, visit www.ventripoint.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The VentriPoint system, called Angelo, is of special value for doing what is called right-heart analysis, where the physician needs a clear view of the portion of the heart that pumps blood to the lungs for oxygenation. It is normally difficult to image the right heart using ultrasound, due to the obstruction of the ribs. As a result, physicians often use MRI imaging to get the necessary detail, even though MRI imaging costs more and is more difficult for the patient, especially for children. The VentriPoint system provides the needed heart information without requiring an MRI, but rather with easy-to-use and far less expensive ultrasound technology. It removes the need to sedate children and for second visits.
The VentriPoint system has key applications for congenital heart disease and pulmonary arterial hypertension, and is being researched for a number of other applications:
• Single ventricle
• Perimount (R) Valves
• Ebsteins
• Workflow analysis
• Economic analysis
• RV to PA conduit
• Left ventricle
• Heart failure
• Coronary artery disease
The system has already been installed in major cardiac centers in Canada, Europe, and North America, and has also been the subject of scientific publications in major heart journals.
For more information, visit www.ventripoint.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Biostem U.S. Corporation (HAIR) Spammed Aggressively
We have observed an unsolicited emails spamming Biostem. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue.
Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page, visit www.basics.qualitystocks.net.
QualityStocks also helps protect investors by rating thousands of OTC companies and research firms based on their investor relations and transparency practices. To see the list of rated companies, visit: www.qualitystocks.net/companies.php.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page, visit www.basics.qualitystocks.net.
QualityStocks also helps protect investors by rating thousands of OTC companies and research firms based on their investor relations and transparency practices. To see the list of rated companies, visit: www.qualitystocks.net/companies.php.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
VistaGen Therapeutics, Inc. (VSTA) Issues Update on $36M Strategic Financing Agreement with Autlion
VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, recently delivered an overview of key developments involving its CardioSafe 3D™ and LiverSafe 3D™ bioassay systems in poster presentations at the 11th Annual Meeting of the International Society of Stem Cell Research (ISSCR), the largest forum for stem cell and regenerative medicine professionals from around the world, held last week in Boston, Massachusetts.
Dr. Hai-Qing Xian, Senior Scientist, presented VistaGen’s poster entitled “Cardiotoxicity Assessment of Anti-Cancer Kinase Inhibitors using Human Pluripotent Stem Cell-Derived Cardiomyocyte Based Assays,” which detailed important developments demonstrating that CardioSafe 3D™, VistaGen’s high throughput, human heart cell-based bioassay, is a clinically predictive system for preclinical cardiac safety screening of anti-cancer drug candidates, including small molecule kinase inhibitors (KIs), a new category of drugs that have revolutionized cancer therapy due to decreased systemic toxicity and increased target cell efficacy compared to classic cancer drugs, as well as other therapeutic compounds. VistaGen also demonstrated the utility of CardioSafe 3D™ to detect cardiac toxicities of well-known anti-cancer KIs, including imatinib, dasatinib, sunitinib, erlotinib, and temsirolimus, which have been associated with adverse clinical cardiac events that were not detected during the drug development process. As demonstrated in the poster presentation, CardioSafe 3D™ successfully detected cardiotoxicity induced by representative compounds from different KI categories. Additionally, the bioassay system provided clues to the major mechanisms of cardiac cytotoxicity induced by each compound, thus enabling not only the identification of toxicities early in the drug development process, but also discovery of potential mechanisms of action.
Dr. Kristina Bonham, Senior Scientist, Hepatocyte Biology Project Leader, presented VistaGen’s poster entitled “Semi–quantitative assay of CYP3A4 allows the identification and selection of mature human stem cell derived hepatocytes,” which detailed developments indicating that LiverSafe 3D™, VistaGen’s human liver cell-based bioassay, can monitor the induction of the key metabolic enzyme, CYP3A4, and its expression level over time. Using an optimized protocol for the differentiation of hepatocyte-like cells, VistaGen demonstrated levels of CYP3A4 mRNA approaching that in human adult liver on a per cell basis. The reported data suggest that VistaGen’s liver cells have many of the functional properties of mature adult liver cells, enabling multiple functional analyses and providing a powerful system to evaluate the effects of drug candidates on CYP3A4 expression and liver function, offering a valuable aid for assessing potential drug candidates for toxicity and adverse drug-drug interactions.
H. Ralph Snodgrass, PhD, VistaGen’s President and Chief Scientific Officer, emphasized, “For the first time, our technology has caught up with the dreams and visions we had 15 years ago when we founded VistaGen. We now have the type and quality of human cell-based biological assay systems that provide real insight into both the therapeutic and toxic effects of new drug candidates long before they are ever tested in humans. Next-generation biological assays can now provide important preclinical human data that will increase the probability of selecting safer and effective therapeutics for clinical development.”
“It is evident from the mood, tone and scientific discussions throughout the ISSCR conference that this is the most exciting time in the history of stem cell research,” added Dr. Snodgrass. “We anticipate that we will see an explosion over the next ten years in the contribution of human pluripotent stem cell-based biological assays to drug development, in parallel with phenomenal advancements in the therapeutic uses of mature cells and tissues derived from human pluripotent stem cells to treat some of the most intractable human diseases and conditions. Our team is truly fortunate and excited about being a part of this transformational process.”
For more information, visit www.vistagen.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Dr. Hai-Qing Xian, Senior Scientist, presented VistaGen’s poster entitled “Cardiotoxicity Assessment of Anti-Cancer Kinase Inhibitors using Human Pluripotent Stem Cell-Derived Cardiomyocyte Based Assays,” which detailed important developments demonstrating that CardioSafe 3D™, VistaGen’s high throughput, human heart cell-based bioassay, is a clinically predictive system for preclinical cardiac safety screening of anti-cancer drug candidates, including small molecule kinase inhibitors (KIs), a new category of drugs that have revolutionized cancer therapy due to decreased systemic toxicity and increased target cell efficacy compared to classic cancer drugs, as well as other therapeutic compounds. VistaGen also demonstrated the utility of CardioSafe 3D™ to detect cardiac toxicities of well-known anti-cancer KIs, including imatinib, dasatinib, sunitinib, erlotinib, and temsirolimus, which have been associated with adverse clinical cardiac events that were not detected during the drug development process. As demonstrated in the poster presentation, CardioSafe 3D™ successfully detected cardiotoxicity induced by representative compounds from different KI categories. Additionally, the bioassay system provided clues to the major mechanisms of cardiac cytotoxicity induced by each compound, thus enabling not only the identification of toxicities early in the drug development process, but also discovery of potential mechanisms of action.
Dr. Kristina Bonham, Senior Scientist, Hepatocyte Biology Project Leader, presented VistaGen’s poster entitled “Semi–quantitative assay of CYP3A4 allows the identification and selection of mature human stem cell derived hepatocytes,” which detailed developments indicating that LiverSafe 3D™, VistaGen’s human liver cell-based bioassay, can monitor the induction of the key metabolic enzyme, CYP3A4, and its expression level over time. Using an optimized protocol for the differentiation of hepatocyte-like cells, VistaGen demonstrated levels of CYP3A4 mRNA approaching that in human adult liver on a per cell basis. The reported data suggest that VistaGen’s liver cells have many of the functional properties of mature adult liver cells, enabling multiple functional analyses and providing a powerful system to evaluate the effects of drug candidates on CYP3A4 expression and liver function, offering a valuable aid for assessing potential drug candidates for toxicity and adverse drug-drug interactions.
H. Ralph Snodgrass, PhD, VistaGen’s President and Chief Scientific Officer, emphasized, “For the first time, our technology has caught up with the dreams and visions we had 15 years ago when we founded VistaGen. We now have the type and quality of human cell-based biological assay systems that provide real insight into both the therapeutic and toxic effects of new drug candidates long before they are ever tested in humans. Next-generation biological assays can now provide important preclinical human data that will increase the probability of selecting safer and effective therapeutics for clinical development.”
“It is evident from the mood, tone and scientific discussions throughout the ISSCR conference that this is the most exciting time in the history of stem cell research,” added Dr. Snodgrass. “We anticipate that we will see an explosion over the next ten years in the contribution of human pluripotent stem cell-based biological assays to drug development, in parallel with phenomenal advancements in the therapeutic uses of mature cells and tissues derived from human pluripotent stem cells to treat some of the most intractable human diseases and conditions. Our team is truly fortunate and excited about being a part of this transformational process.”
For more information, visit www.vistagen.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The Guitammer Company (GTMM) – Technological Evolution in Motion
The Guitammer Company was founded by musician, composer, and producer Ken McCaw, who was looking for a way to commercialize a patented guitar accessory called the Hammer Jammer. The next product to emerge from Guitammer was the solution to a problem McCaw and his drummer were experiencing in wanting to be able to feel the low end without turning the stage monitors up so loud that it disturbed the rest of the band.
This was the moment the idea for ButtKicker® brand low frequency audio transducers were born, offering monitoring, timing, and synchronization by allowing the musicians to feel the low-end beat. With the help of Marvin Clamme, former sound engineer for Tom Jones, Merle Haggard, the Beach Boys and others, McCaw developed the original ButtKicker transducer prototypes.
After several years of product development, a patent was issued for ButtKicker brand low frequency audio transducers, which went to market in late 1999. Now, the company is a revenue-generating company with a worldwide market reach.
The company’s product line includes the original ButtKicker transducer, designed for musicians’ monitoring, timing and synchronization. Pearl Drums recently released the Pearl Throne Thumper, by ButtKicker, a co-developed product.
The company’s newly patented broadcast technology, ButtKicker LIVE!® relays the excitement, impact, and feeling of sporting events to broadcast along with the sound and video. The technology is available for cable, satellite, fiber optic, IPTV, and “over-the-air” broadcast and has been successfully tested with several major content (sports) providers.
The ButtKicker low frequency transducer is ideal for home theater use, reproducing bass and special effects from the subwoofer and .1 LFE sound tracks. The technology literally shakes the couch or home theater seating in sync with the movie, music, or game.
The ButtKicker Gamer was specifically designed for gamers who want to “feel” the action from video games and simulators. Users can turn down or turn off the subwoofer and still feel all the bass – even while using headphones.
ButtKicker® brand products are also used in movie theaters, simulation rides, dance floors, 4D theaters, planetariums, science centers, amusement parks, and attractions all over the world to thrill and entertain. ButtKicker 4D theaters allow viewers to “feel” the impacts, special effects and bone-rattling bass. No special encoding is required.
To-date, Guitammer has deployed its technology in nearly 10,000 seats in 12 countries.
For more information, visit www.guitammer.com or www.thebuttkicker.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
This was the moment the idea for ButtKicker® brand low frequency audio transducers were born, offering monitoring, timing, and synchronization by allowing the musicians to feel the low-end beat. With the help of Marvin Clamme, former sound engineer for Tom Jones, Merle Haggard, the Beach Boys and others, McCaw developed the original ButtKicker transducer prototypes.
After several years of product development, a patent was issued for ButtKicker brand low frequency audio transducers, which went to market in late 1999. Now, the company is a revenue-generating company with a worldwide market reach.
The company’s product line includes the original ButtKicker transducer, designed for musicians’ monitoring, timing and synchronization. Pearl Drums recently released the Pearl Throne Thumper, by ButtKicker, a co-developed product.
The company’s newly patented broadcast technology, ButtKicker LIVE!® relays the excitement, impact, and feeling of sporting events to broadcast along with the sound and video. The technology is available for cable, satellite, fiber optic, IPTV, and “over-the-air” broadcast and has been successfully tested with several major content (sports) providers.
The ButtKicker low frequency transducer is ideal for home theater use, reproducing bass and special effects from the subwoofer and .1 LFE sound tracks. The technology literally shakes the couch or home theater seating in sync with the movie, music, or game.
The ButtKicker Gamer was specifically designed for gamers who want to “feel” the action from video games and simulators. Users can turn down or turn off the subwoofer and still feel all the bass – even while using headphones.
ButtKicker® brand products are also used in movie theaters, simulation rides, dance floors, 4D theaters, planetariums, science centers, amusement parks, and attractions all over the world to thrill and entertain. ButtKicker 4D theaters allow viewers to “feel” the impacts, special effects and bone-rattling bass. No special encoding is required.
To-date, Guitammer has deployed its technology in nearly 10,000 seats in 12 countries.
For more information, visit www.guitammer.com or www.thebuttkicker.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
CytoSorbents Corp. (CTSO) Begins $1 Million US Army Contract
CytoSorbents is a critical care-focused therapeutic device company using blood purification to modulate the immune system, with the goal of preventing or treating multiple organ failures in life-threatening illnesses. The company’s flagship product, CytoSorb, is approved in Europe as a safe and effective extracorporeal cytokine filter. It is designed to reduce the “cytokine storm” that can cause organ failure or death.
The company reported today that it successfully completed negotiations and commenced work on the previously announced $1 million Phase II SBIR (Small Business Innovation Research) contract in trauma and burn injury from the U.S. Army. The work, supported by the U.S. Army Medical Research and Material Command, has received committed funding of $1.15 million to date.
Cytosorbents, over the next year, will continue its collaboration with some of the leading medical researchers in the U.S. military to explore the use of its CytoSorb cytokine filter and newly developed technologies to treat both trauma along with burn and smoke inhalation injuries in large animal models. After the successful completion of Phase II work, the company will be eligible to apply for a Phase III SBIR award that would then be used to fund an acceleration of human clinical testing in the areas of burn injury and/or trauma.
The company is already engaged in a separate, recently announced Air Force-funded and FDA-approved 30 patient human pilot study using CytoSorb to treat rhabdomyolysis in trauma patients. This trial will begin in the U.S. later this year.
For additional information about CytoSorbents Corporation and its flagship CytoSorb cytokine filter, please visit www.cytosorbents.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The company reported today that it successfully completed negotiations and commenced work on the previously announced $1 million Phase II SBIR (Small Business Innovation Research) contract in trauma and burn injury from the U.S. Army. The work, supported by the U.S. Army Medical Research and Material Command, has received committed funding of $1.15 million to date.
Cytosorbents, over the next year, will continue its collaboration with some of the leading medical researchers in the U.S. military to explore the use of its CytoSorb cytokine filter and newly developed technologies to treat both trauma along with burn and smoke inhalation injuries in large animal models. After the successful completion of Phase II work, the company will be eligible to apply for a Phase III SBIR award that would then be used to fund an acceleration of human clinical testing in the areas of burn injury and/or trauma.
The company is already engaged in a separate, recently announced Air Force-funded and FDA-approved 30 patient human pilot study using CytoSorb to treat rhabdomyolysis in trauma patients. This trial will begin in the U.S. later this year.
For additional information about CytoSorbents Corporation and its flagship CytoSorb cytokine filter, please visit www.cytosorbents.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
StreamTrack, Inc. (STTK) Unveils New UniversalPlayer with Capacity Upgrade
StreamTrack today announced the release of its upgraded UniversalPlayer™. The new platform represents a major step forward in its technology. This advancement includes performance optimizations, display improvements, and functional upgrades to support the scalability of up to 250,000 concurrent listeners.
Performance optimizations include faster loading time, CDN support, improved caching optimization, and a smaller footprint with smoother execution. Furthermore, stations can now pick between 11 different new themes to customize the look and feel of their player. Functionally, new stream formats supported now include: AAC, AAC+, RTMP, HDS, and HLS. Improvements to optimize flash functionality were also implemented.
StreamTrack CEO Michael Hill stated, “I am very proud of our team for developing such a powerful and innovative product. We have been working on this UniversalPlayer™ for over 6 months, and to see the finished product work so efficiently is a great accomplishment. We are continually trying to improve our Platform and this release demonstrates this. To support our projected increase in listeners, completing this UniversalPlayer™ was required.”
“We are now ready to go to scale with our proven business model: decreasing expense for broadcasters while increasing revenue for everyone in the supply and demand chain,” added Hill. “With the new UniversalPlayer™ being deployed at scale along with our patent-pending instream video ad insertion model, the future looks bright.”
For more information, visit www.streamtrack.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Performance optimizations include faster loading time, CDN support, improved caching optimization, and a smaller footprint with smoother execution. Furthermore, stations can now pick between 11 different new themes to customize the look and feel of their player. Functionally, new stream formats supported now include: AAC, AAC+, RTMP, HDS, and HLS. Improvements to optimize flash functionality were also implemented.
StreamTrack CEO Michael Hill stated, “I am very proud of our team for developing such a powerful and innovative product. We have been working on this UniversalPlayer™ for over 6 months, and to see the finished product work so efficiently is a great accomplishment. We are continually trying to improve our Platform and this release demonstrates this. To support our projected increase in listeners, completing this UniversalPlayer™ was required.”
“We are now ready to go to scale with our proven business model: decreasing expense for broadcasters while increasing revenue for everyone in the supply and demand chain,” added Hill. “With the new UniversalPlayer™ being deployed at scale along with our patent-pending instream video ad insertion model, the future looks bright.”
For more information, visit www.streamtrack.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
GRILLiT, Inc. (GRLT) Sets New Record Date for Dividend
GRILLiT, operator of healthy, fast-casual restaurants offering American, Asian Fusion, and Latin American food styles, today told investors that it is postponing the record date for its previously announced common stock dividend. Instead of June 28, 2013, the record date for the stock dividend will be July 15, 2013.
All shareholders of GRILLiT owning common shares on the record date of July 15, 2013, will receive four shares of GRILLiT common stock for every share held by such shareholder. The dividended common shares will be “restricted” as defined in the Securities Act of 1933. Rule 144 allows for the public resale of restricted securities only if certain holding period and other conditions are satisfied.
Per FINRA regulations, the company is required to provide notice to and receive acceptance from FINRA prior to the actual distribution of the dividend. As long as FINRA does not cause any unforeseen delays, GRILLiT anticipates distributing the stock dividend within three to four weeks. The payment of the dividend will not require an increase in the total number of authorized shares of common stock nor is there a need for an exchange of certificates.
For more information, visit www.GRILLiTinc.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
All shareholders of GRILLiT owning common shares on the record date of July 15, 2013, will receive four shares of GRILLiT common stock for every share held by such shareholder. The dividended common shares will be “restricted” as defined in the Securities Act of 1933. Rule 144 allows for the public resale of restricted securities only if certain holding period and other conditions are satisfied.
Per FINRA regulations, the company is required to provide notice to and receive acceptance from FINRA prior to the actual distribution of the dividend. As long as FINRA does not cause any unforeseen delays, GRILLiT anticipates distributing the stock dividend within three to four weeks. The payment of the dividend will not require an increase in the total number of authorized shares of common stock nor is there a need for an exchange of certificates.
For more information, visit www.GRILLiTinc.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Chembio Diagnostics, Inc. (CEMI) Announces Membership in Russell Global Index
Point-of-care diagnostics test leader Chembio Diagnostics announced it will soon join the Russell Global Index. According to a preliminary list of additions posted on June 21 at www.russell.com/indexes, the listing will happen on June 28, when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes.
Russell Global Index membership remains in place for one year and means automatic inclusion in the appropriate large-cap, small-cap and all-cap indexes, as well as the applicable style, sector, and country indexes. Membership for Russell’s equity indexes is determined chiefly by objective market-capitalization rankings and style attributes. Chembio’s stock will be included in Russell’s Micro-Cap Index.
Chembio continues to build momentum with both sales and product development and is currently in a very strong position. The company’s membership in the Russell Global Index is occurring at a time when Chembio has experienced four consecutive years of profitability and revenue growth. The company now has three FDA-approved rapid HIV tests, including its oral fluid HIV test which is pending CLIA waiver and strong international sales. Chembio is additionally developing a robust POC product pipeline based on the company’s patented DPP technology.
“We are very pleased to join the list of successful companies comprising the Russell Global Index and look forward to the enhanced visibility of our membership,” said Chembio Chairman and CEO Lawrence A. Siebert.
Chembio Diagnostics is engaged in developing, manufacturing, licensing, and marketing proprietary rapid diagnostic tests in the burgeoning $10 billion point-of-care testing market. The company is headquartered in Medford, N.Y., and has approximately 170 employees. Chembio is licensed by the FDA and the USDA and is also certified for the global market under the International Standards Organization (ISO) directive 13.485.
For more information, visit www.chembio.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Russell Global Index membership remains in place for one year and means automatic inclusion in the appropriate large-cap, small-cap and all-cap indexes, as well as the applicable style, sector, and country indexes. Membership for Russell’s equity indexes is determined chiefly by objective market-capitalization rankings and style attributes. Chembio’s stock will be included in Russell’s Micro-Cap Index.
Chembio continues to build momentum with both sales and product development and is currently in a very strong position. The company’s membership in the Russell Global Index is occurring at a time when Chembio has experienced four consecutive years of profitability and revenue growth. The company now has three FDA-approved rapid HIV tests, including its oral fluid HIV test which is pending CLIA waiver and strong international sales. Chembio is additionally developing a robust POC product pipeline based on the company’s patented DPP technology.
“We are very pleased to join the list of successful companies comprising the Russell Global Index and look forward to the enhanced visibility of our membership,” said Chembio Chairman and CEO Lawrence A. Siebert.
Chembio Diagnostics is engaged in developing, manufacturing, licensing, and marketing proprietary rapid diagnostic tests in the burgeoning $10 billion point-of-care testing market. The company is headquartered in Medford, N.Y., and has approximately 170 employees. Chembio is licensed by the FDA and the USDA and is also certified for the global market under the International Standards Organization (ISO) directive 13.485.
For more information, visit www.chembio.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Access Pharmaceuticals, Inc. (ACCP) Reports Favorable MuGard™ Trial Results, Presented at MASCC/ISOO International Symposium on Supportive Care in Cancer
Dr. Ron R. Allison of Carolina Radiation Medicine, Greenville, NC, has presented top-line results from a phase IV clinical trial evaluating Access Pharmaceuticals’ MuGard™ Mucoadhesive Oral Wound Rinse at the MASCC/ISOO International Symposium on Supportive Care in Cancer in Berlin, Germany. The study evaluated the efficacy of MuGard in controlling symptoms caused by oral mucositis, a side effect of some radiation and chemotherapy cancer treatments.
The presentation, entitled “The Multi-Institutional, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy of MuGard in Mitigating Oral Mucositis (OM) in Chemoradiation-Treated Head and Neck Cancer Patients” summarized top-line data on 78 of the total 120 patients who were enrolled in the study. The patients were randomized 1:1 to receive either MuGard or placebo. The analysis covered 37 evaluable MuGard patients and 41 evaluable placebo patient.
Data show that MuGard successfully met the primary study endpoint of reducing symptoms of oral mucositis, demonstrating that patients receiving MuGard experienced a statistically significant reduction versus placebo in mouth and throat soreness. In addition, the company reports that fewer patients receiving MuGard had ulcerative at the end of radiation therapy.
“For this head and neck cancer population, the debilitating side effect of oral mucositis remains one of our most significant clinical challenges. The benefits of MuGard shown in these results are critically important, both clinically and from a patient quality-of-life perspective,” Dr. Ron R. Allison, a principal investigator in the MuGard trial, Carolina Radiation Medicine, stated in the press release. “MuGard helps patients manage their mucositis during these tough treatment regimens.”
MuGard was launched in 2010 after receiving 510(k) clearance from the U.S. Food and Drug Administration – the product is available by prescription only, meeting a largely unmet need in among cancer patients receiving chemotherapy and/or radiation.
“Oral mucositis is a significant medical need for this population and these study results provide strong evidence of MuGard’s effectiveness in managing the mouth and throat soreness associated with it,” stated expert on cancer-treatment mucosal toxicities, Stephen T. Sonis, DMD, DMSc, Clinical Professor of Oral Medicine at Harvard and consultant to Clinical Assistance Programs for this trial.
For more information, visit www.accesspharma.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The presentation, entitled “The Multi-Institutional, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy of MuGard in Mitigating Oral Mucositis (OM) in Chemoradiation-Treated Head and Neck Cancer Patients” summarized top-line data on 78 of the total 120 patients who were enrolled in the study. The patients were randomized 1:1 to receive either MuGard or placebo. The analysis covered 37 evaluable MuGard patients and 41 evaluable placebo patient.
Data show that MuGard successfully met the primary study endpoint of reducing symptoms of oral mucositis, demonstrating that patients receiving MuGard experienced a statistically significant reduction versus placebo in mouth and throat soreness. In addition, the company reports that fewer patients receiving MuGard had ulcerative at the end of radiation therapy.
“For this head and neck cancer population, the debilitating side effect of oral mucositis remains one of our most significant clinical challenges. The benefits of MuGard shown in these results are critically important, both clinically and from a patient quality-of-life perspective,” Dr. Ron R. Allison, a principal investigator in the MuGard trial, Carolina Radiation Medicine, stated in the press release. “MuGard helps patients manage their mucositis during these tough treatment regimens.”
MuGard was launched in 2010 after receiving 510(k) clearance from the U.S. Food and Drug Administration – the product is available by prescription only, meeting a largely unmet need in among cancer patients receiving chemotherapy and/or radiation.
“Oral mucositis is a significant medical need for this population and these study results provide strong evidence of MuGard’s effectiveness in managing the mouth and throat soreness associated with it,” stated expert on cancer-treatment mucosal toxicities, Stephen T. Sonis, DMD, DMSc, Clinical Professor of Oral Medicine at Harvard and consultant to Clinical Assistance Programs for this trial.
For more information, visit www.accesspharma.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Minerco Resources, Inc. (MINE) Subsidiary Receives License for Universal Product Code Company Prefix
Minerco Resources, a progressive developer, producer, and provider of worldwide commodities solutions, today announced that Level 5 Beverage Company, Inc., the company’s subsidiary, has received its Universal Product Code (U.P.C.) Company Prefix from GS1 US.
The License was issued to Level 5 for its GS1 Company Prefix (0851012005), its U.P.C. Company Prefix (851012005), and its Global Location Number (GLN 0851012005008). This license, including GS1 membership, entitles Level 5 to create up to 100 distinct Global Trade Item Numbers (GTINs) including U.P.C.s and SKU numbers.
Used exclusively within GS1 identification standards, the GS1 Company Prefix may be expressed in GS1 approved bar code applications for global data synchronization, network registration, and many other applications reserved for the GS1 System. Please visit www.gs1.org for more information.
A specific type of barcode, the Universal Product Code (UPC) is widely used in multiple countries for tracking trade items in stores and distribution networks. The UPC barcode is primarily used for the scanning of trade items at the point of sale, per GS1 specifications
John Powers, the CEO of the company said, “Another step of our launch of Level 5 is complete. Obtaining the GS1 and UPC Company Prefix License (including license to create SKU numbers) gives us the green light to proceed to the next step. Additionally, this membership and license from GS1 US will allow for future ease of expansion to numerous markets and products. As always, we will keep our shareholders and consumers informed as we continue to launch Level 5.”
For more information on Minerco Resources, please visit www.minercoresources.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The License was issued to Level 5 for its GS1 Company Prefix (0851012005), its U.P.C. Company Prefix (851012005), and its Global Location Number (GLN 0851012005008). This license, including GS1 membership, entitles Level 5 to create up to 100 distinct Global Trade Item Numbers (GTINs) including U.P.C.s and SKU numbers.
Used exclusively within GS1 identification standards, the GS1 Company Prefix may be expressed in GS1 approved bar code applications for global data synchronization, network registration, and many other applications reserved for the GS1 System. Please visit www.gs1.org for more information.
A specific type of barcode, the Universal Product Code (UPC) is widely used in multiple countries for tracking trade items in stores and distribution networks. The UPC barcode is primarily used for the scanning of trade items at the point of sale, per GS1 specifications
John Powers, the CEO of the company said, “Another step of our launch of Level 5 is complete. Obtaining the GS1 and UPC Company Prefix License (including license to create SKU numbers) gives us the green light to proceed to the next step. Additionally, this membership and license from GS1 US will allow for future ease of expansion to numerous markets and products. As always, we will keep our shareholders and consumers informed as we continue to launch Level 5.”
For more information on Minerco Resources, please visit www.minercoresources.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
QualityStocks Productions Releases Rafarma Pharmaceuticals, Inc. (RAFA) Video Exposing Company’s Strategic Position
The Russian pharmaceutical sector is roaring forward, estimated to reach a value of $10.7 billion by 2014 and $60 billion by 2020, fueled by the Russian Government’s initiatives to bolster the country’s domestic pharmaceutical market. Rafarma Pharmaceuticals aims to take its fair share of the market and emerge as one of the Top 3 Russian pharmaceutical companies within the next decade.
To reach this goal, Rafarma has built a new world-class 270,000 square-foot manufacturing plant in a strategic location and operated by a highly classified management team.
A recent video published by QualityStocks Productions highlights Rafarma’s position in the burgeoning industry, its stellar production facility, and how the company has contributed to the economic growth in Russia.
“The Russian Federation has expressed great interest in entering the big pharma initiative. With this initiative, Rafarma is poised and place in a location and in a way that we believe Rafarma will enter that big pharma market,” Dave Anderson, CEO of Rafarma’s USA Operations, says in the video.
Rafarma’s manufacturing facility is located in Terbuny, Lipetsk Region, Russia, positioned to raise the economic standard of the area and employ local citizens under the leadership of experienced a director and team of engineers.
Armed with skilled and trained employees, the company’s facility is comprehensive in its capabilities.
“It’s not just a manufacturing facility. It’s also developmental labs,” says Jack Brannelly, outside counsel for Rafarma. “They create their own products and patent those products here. But they also have the capacity to manufacture for other companies. They can create generic drugs.”
From its technologically advanced facility, Rafarma is positioned to modernize Russia’s domestic medical/pharmaceutical industry, leveraging the Russian government’s aggressive strategy. What differentiate Rafarma from its peers are its state-of-the art facility and industry qualifications.
“Rafarma has been given the highest qualifications in the international standards. This sets us apart from many other pharmaceutical companies and allows us to be able to provide that excellent service,” says Anderson.
For more information, visit www.rafarma.us
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
To reach this goal, Rafarma has built a new world-class 270,000 square-foot manufacturing plant in a strategic location and operated by a highly classified management team.
A recent video published by QualityStocks Productions highlights Rafarma’s position in the burgeoning industry, its stellar production facility, and how the company has contributed to the economic growth in Russia.
“The Russian Federation has expressed great interest in entering the big pharma initiative. With this initiative, Rafarma is poised and place in a location and in a way that we believe Rafarma will enter that big pharma market,” Dave Anderson, CEO of Rafarma’s USA Operations, says in the video.
Rafarma’s manufacturing facility is located in Terbuny, Lipetsk Region, Russia, positioned to raise the economic standard of the area and employ local citizens under the leadership of experienced a director and team of engineers.
Armed with skilled and trained employees, the company’s facility is comprehensive in its capabilities.
“It’s not just a manufacturing facility. It’s also developmental labs,” says Jack Brannelly, outside counsel for Rafarma. “They create their own products and patent those products here. But they also have the capacity to manufacture for other companies. They can create generic drugs.”
From its technologically advanced facility, Rafarma is positioned to modernize Russia’s domestic medical/pharmaceutical industry, leveraging the Russian government’s aggressive strategy. What differentiate Rafarma from its peers are its state-of-the art facility and industry qualifications.
“Rafarma has been given the highest qualifications in the international standards. This sets us apart from many other pharmaceutical companies and allows us to be able to provide that excellent service,” says Anderson.
For more information, visit www.rafarma.us
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Thursday, June 27, 2013
Far East Energy Corp. (FEEC) Spuds An Incredible Well Per Day for Two Weeks Straight as 43rd Well Goes in at Shouyang Block
Far East Energy, with offices in Beijing and Taiyuan, the US-listed little powerhouse of a hydrocarbon developer that is focused on rich coalbed methane in Shanxi Province at their Shouyang Block (Shouyang PSC), reported today that they have spud their 43rd well of the year, as 13 new wells have gone in since the last program update, just 13 days ago, on June 14th.
This is an incredibly efficient pace of development, only sweetened by the fact that 4 wells have also reached their target depths, with the associated fracking program for the year also fully underway. Such rapid progress is great news for FEEC’s 2013 field operations, especially as preliminary data comes in off the SYSE-09 appraisal well in the southeast of the block (completed to just over 4.5k feet), showing a nice slab of No. 15 coal seam that is around 32.8 feet thick.
Now, looking at the fact that this is deep in the southeast of the block, some 21.75 miles from the main 1-H production area and that results came back with exceptionally high gas content readings, it should start to dawn on investors how much potential there is in the Shouyang for FEEC. The company certainly realizes the massive potential here and they are making huge infrastructural strides so far in 2013 to capture that potential.
CEO of FEEC, Michael McElwrath, was pleased to note that the company now has 30 rigs operating in the field, having blown past the original target of 25 and that they are doing phenomenal completion, at a rate of around a well a day for two weeks now. To even a sector novice this should appear as quite an impressive run for FEEC, something that is newsworthy in and of itself. Indeed, McElwrath was keen to point out this fact and explain that this level of activity far surpasses the company’s peers operating within the PRC, chalking the feat up to brilliant leadership by field ops GM’s Brent Lowson and Matt Murphy, as well as the stellar team of field personnel they have assembled.
Senior VP of Exploration for FEEC, Alex Yang, was bullish on the potential in the southeast block especially, something which is now even more firmly reinforced by the new appraisal well data. Yang characterized the coal seams of the entire eastern half of the block as being of exceptional target quality. Thickness, permeability, and high content spells a bright future for production or reserves in the eastern Shouyang, and FEEC shareholders are likely beaming today as this excellent news hits the wires.
For more info on Far East Energy, visit www.FarEastEnergy.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
This is an incredibly efficient pace of development, only sweetened by the fact that 4 wells have also reached their target depths, with the associated fracking program for the year also fully underway. Such rapid progress is great news for FEEC’s 2013 field operations, especially as preliminary data comes in off the SYSE-09 appraisal well in the southeast of the block (completed to just over 4.5k feet), showing a nice slab of No. 15 coal seam that is around 32.8 feet thick.
Now, looking at the fact that this is deep in the southeast of the block, some 21.75 miles from the main 1-H production area and that results came back with exceptionally high gas content readings, it should start to dawn on investors how much potential there is in the Shouyang for FEEC. The company certainly realizes the massive potential here and they are making huge infrastructural strides so far in 2013 to capture that potential.
CEO of FEEC, Michael McElwrath, was pleased to note that the company now has 30 rigs operating in the field, having blown past the original target of 25 and that they are doing phenomenal completion, at a rate of around a well a day for two weeks now. To even a sector novice this should appear as quite an impressive run for FEEC, something that is newsworthy in and of itself. Indeed, McElwrath was keen to point out this fact and explain that this level of activity far surpasses the company’s peers operating within the PRC, chalking the feat up to brilliant leadership by field ops GM’s Brent Lowson and Matt Murphy, as well as the stellar team of field personnel they have assembled.
Senior VP of Exploration for FEEC, Alex Yang, was bullish on the potential in the southeast block especially, something which is now even more firmly reinforced by the new appraisal well data. Yang characterized the coal seams of the entire eastern half of the block as being of exceptional target quality. Thickness, permeability, and high content spells a bright future for production or reserves in the eastern Shouyang, and FEEC shareholders are likely beaming today as this excellent news hits the wires.
For more info on Far East Energy, visit www.FarEastEnergy.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Mabwe Minerals Inc. (MBMI) Prepares for Commercial Production Leveraging Pending, Current Partnerships
Mabwe Minerals operates through its Zimbabwe affiliate, Mabwe Corp. Ltd., as a U.S.-based natural resources and hard asset company focused on the mining, logistics, and commercial sales of industrial minerals and metals.
The company’s primary focus is on barite, a weighting agent for drilling fluids in oil and gas drilling operations, and is also used for medial, paint, and automotive applications. Moving from a development phase company into commercial barite production, the company is preparing to benefit from rising global demand.
MBMI’s Dodge Mine project is comprised of three hydrothermal mountains with multiple deposits of barite, limestone, and talc. A third-party oil & gas drilling sector geologist recently classified the barite deposits at Dodge Mine as “world class” based on their high percentage content of barium sulfate (BaSO4).
Based on its findings, MBMI is negotiating strategic partnerships with Steinbock Minerals, which specializes in the worldwide distribution, marketing, and sales of industrial metals, including barite; and Yasheya Ltd., which specializes in the global shipment of industrial metals.
In regards to the pending partnerships, MBMI is preparing samples for qualification into Steinbock’s barite customer base with anticipation it will commence shipments of chemical, off-white and bright-white barite types for high-end market applications via another strategic partnership with PHI Commodities.
MBMI has already established a partnership with grain importer PHI in which MBMI has exclusive load rights to PHI’s fleet of 80 rail wagons for the non-stop return of loads from the Shamva Rail Depot near Dodge Mine to the Port of Beira, Mozambique.
MBMI recently secured a long term, $9 million Master Supplier Agreement (MSA) with Baker Hughes, an established oil & gas drilling sector company. The deal represents 3 million metric tons of American Petroleum Institute (API) grade barite to be delivered at a rate of 220,000 metric tons per year.
Supported by its partnership with PHI, MBMI will utilize its expanded land transportation capacity to Port Beira to expand mining production and support non-API customers scheduled to begin white barite qualification upon delivery of samples later this year.
For more information, visit www.raptorresourcesholdings.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The company’s primary focus is on barite, a weighting agent for drilling fluids in oil and gas drilling operations, and is also used for medial, paint, and automotive applications. Moving from a development phase company into commercial barite production, the company is preparing to benefit from rising global demand.
MBMI’s Dodge Mine project is comprised of three hydrothermal mountains with multiple deposits of barite, limestone, and talc. A third-party oil & gas drilling sector geologist recently classified the barite deposits at Dodge Mine as “world class” based on their high percentage content of barium sulfate (BaSO4).
Based on its findings, MBMI is negotiating strategic partnerships with Steinbock Minerals, which specializes in the worldwide distribution, marketing, and sales of industrial metals, including barite; and Yasheya Ltd., which specializes in the global shipment of industrial metals.
In regards to the pending partnerships, MBMI is preparing samples for qualification into Steinbock’s barite customer base with anticipation it will commence shipments of chemical, off-white and bright-white barite types for high-end market applications via another strategic partnership with PHI Commodities.
MBMI has already established a partnership with grain importer PHI in which MBMI has exclusive load rights to PHI’s fleet of 80 rail wagons for the non-stop return of loads from the Shamva Rail Depot near Dodge Mine to the Port of Beira, Mozambique.
MBMI recently secured a long term, $9 million Master Supplier Agreement (MSA) with Baker Hughes, an established oil & gas drilling sector company. The deal represents 3 million metric tons of American Petroleum Institute (API) grade barite to be delivered at a rate of 220,000 metric tons per year.
Supported by its partnership with PHI, MBMI will utilize its expanded land transportation capacity to Port Beira to expand mining production and support non-API customers scheduled to begin white barite qualification upon delivery of samples later this year.
For more information, visit www.raptorresourcesholdings.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
GNCC Capital, Inc. (GNCP) is More Than Just Gold
Although GNCC Capital, holder of a number of mining properties in Arizona, has a stated focus on gold, the company is also actively engaged in possible silver finds.
One of the company’s key silver properties is the Kit Carson Silver Project, made up of approximately 411 acres in central Arizona. It includes 24 unpatented lode mining claims, plus a 50% undivided interest in the mineral rights to the Lady Alde patented lode mining claim. The unpatented mining claims are located on land administered by the US Bureau of Land Management. The project is in the Big Bug Mining District, and three of the company’s mines at this property have been mined in the past for precious and base metals: Lookout, Kit Carson and Lady Alde.
The Lookout Silver Mine was operated as recently as 1979, but has only been worked to a depth of 200 feet. GNCC intends to begin exploration by surface geochemical sampling along the three main vein systems, with any anomalies encountered considered as potential drill targets.
The Kit Carson Silver Project is located between two major past producing mines. Adjoining the northeast end of the project area is the Iron King Mine, which produced gold, silver, lead, and zinc for a Phelps Dodge predecessor until the late 1960’s. Adjoining the Kit Carson Silver Project is the Gladstone – McCabe Gold Mine, which was last operated by Magma (later BHP) in the 1980’s. A major part of the GNCC rationale for acquiring Kit Carson Silver was the prospect that the rich gold and silver deposits at Iron King and Gladstone-McCabe continue into the company’s property, which was only mined to shallow depths.
Iron King produced, during the period from 1907 until 1964, a total of 616,493 ounces of gold, 18,494,491 ounces of silver, 125,375 tons of lead, 367,569 tons of zinc, and 9,551 tons of copper. This would amount to $2.6 Billion of production at January 2011 commodity price levels.
For more information, visit www.GNCC-Capital.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
One of the company’s key silver properties is the Kit Carson Silver Project, made up of approximately 411 acres in central Arizona. It includes 24 unpatented lode mining claims, plus a 50% undivided interest in the mineral rights to the Lady Alde patented lode mining claim. The unpatented mining claims are located on land administered by the US Bureau of Land Management. The project is in the Big Bug Mining District, and three of the company’s mines at this property have been mined in the past for precious and base metals: Lookout, Kit Carson and Lady Alde.
The Lookout Silver Mine was operated as recently as 1979, but has only been worked to a depth of 200 feet. GNCC intends to begin exploration by surface geochemical sampling along the three main vein systems, with any anomalies encountered considered as potential drill targets.
The Kit Carson Silver Project is located between two major past producing mines. Adjoining the northeast end of the project area is the Iron King Mine, which produced gold, silver, lead, and zinc for a Phelps Dodge predecessor until the late 1960’s. Adjoining the Kit Carson Silver Project is the Gladstone – McCabe Gold Mine, which was last operated by Magma (later BHP) in the 1980’s. A major part of the GNCC rationale for acquiring Kit Carson Silver was the prospect that the rich gold and silver deposits at Iron King and Gladstone-McCabe continue into the company’s property, which was only mined to shallow depths.
Iron King produced, during the period from 1907 until 1964, a total of 616,493 ounces of gold, 18,494,491 ounces of silver, 125,375 tons of lead, 367,569 tons of zinc, and 9,551 tons of copper. This would amount to $2.6 Billion of production at January 2011 commodity price levels.
For more information, visit www.GNCC-Capital.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The Aristocrat Group Corp. (ASCC) Focuses on Texas Market for Distribution Business
Today before the opening bell, the Aristocrat Group told investors that it is targeting Texas with its beverage distribution strategy. The Houston Business Journal recently reported that the Lone Star State ranked No. 2 in the nation for total beer consumption. In 2011, 605 million gallons sold, which is the equivalent of 34.6 gallons purchased per every resident of legal age.
Recognizing the state’s market size and central location, ASCC has chosen Texas as its entry point into the beverage distribution business. The company plans to offer exciting and unique product choices currently unavailable in the market. It’s already in talks with foreign brewers to be the exclusive distributer of award-winning import brands in the U.S.
“Texas is the ideal staging ground for our new wholesale subsidiary, TOP Shelf Distributing,” stated ASCC CEO Robert Federowicz. “The state will be among the first where RWB Ultra-Premium Handcrafted Vodka is made available, and we expect to follow up that success by distributing popular imported beers in Texas, as well.”
Of course imported craft beer is only one component of ASCC’s aggressive beverage distribution strategy. The company intends to build a stable of its own successful brands in order to compete in a highly profitable sector alongside LVMH Moet Hennessy Louis Vuitton (LVMUY), Diageo PLC (DEO), BEAM Inc. (BEAM), and Brown-Forman Corp. (BF-B). By handling its own distribution business, ASCC aims to fully capitalize on unprecedented new brand building opportunities through its brand management division, Luxuria Brands.
For more information, visit www.aristocratgroupcorp.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Recognizing the state’s market size and central location, ASCC has chosen Texas as its entry point into the beverage distribution business. The company plans to offer exciting and unique product choices currently unavailable in the market. It’s already in talks with foreign brewers to be the exclusive distributer of award-winning import brands in the U.S.
“Texas is the ideal staging ground for our new wholesale subsidiary, TOP Shelf Distributing,” stated ASCC CEO Robert Federowicz. “The state will be among the first where RWB Ultra-Premium Handcrafted Vodka is made available, and we expect to follow up that success by distributing popular imported beers in Texas, as well.”
Of course imported craft beer is only one component of ASCC’s aggressive beverage distribution strategy. The company intends to build a stable of its own successful brands in order to compete in a highly profitable sector alongside LVMH Moet Hennessy Louis Vuitton (LVMUY), Diageo PLC (DEO), BEAM Inc. (BEAM), and Brown-Forman Corp. (BF-B). By handling its own distribution business, ASCC aims to fully capitalize on unprecedented new brand building opportunities through its brand management division, Luxuria Brands.
For more information, visit www.aristocratgroupcorp.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
International Stem Cell Corp. (ISCO) to Share Parkinson’s Disease Program Data at Society for Neuroscience Annual Meeting
International Stem Cell Corp., a California-based biotechnology company developing novel stem cell based therapies, today told investors that it will be presenting preliminary data from its IND-enabling study in Parkinson’s disease at the Society for Neuroscience annual meeting in San Diego, CA, on November 10th 2013.
The Society for Neuroscience is the world’s largest organization of scientists and clinicians dedicated to understanding the brain and nervous system. Over 30,000 attendees are expected at this year’s annual meeting, making it one of the largest scientific and medical conferences in the world.
ISCO’s Parkinson’s disease program uses human parthenogenetic neural stem cells (hPNSC) which are a novel therapeutic cellular product derived from the company’s proprietary histocompatible human pluripotent stem cells. hPNSC are self-renewing mulitpotent cells that are precursors for the major cells of the central nervous system. The ability of hPNSC to differentiate into dopaminergic (DA) neurons and express neurotrophic factors such as glial derived neurotrophic factor (GDNF) and brain derived neurotrophic factor (BDNF) to protect the nigrostriatal system, offers a new opportunity for the treatment of Parkinson’s disease, especially in cases where current small molecule approaches fail to adequately control the symptoms.
For more information on International Stem Cell Corp. and its Parkinson’s disease program, visit www.internationalstemcell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The Society for Neuroscience is the world’s largest organization of scientists and clinicians dedicated to understanding the brain and nervous system. Over 30,000 attendees are expected at this year’s annual meeting, making it one of the largest scientific and medical conferences in the world.
ISCO’s Parkinson’s disease program uses human parthenogenetic neural stem cells (hPNSC) which are a novel therapeutic cellular product derived from the company’s proprietary histocompatible human pluripotent stem cells. hPNSC are self-renewing mulitpotent cells that are precursors for the major cells of the central nervous system. The ability of hPNSC to differentiate into dopaminergic (DA) neurons and express neurotrophic factors such as glial derived neurotrophic factor (GDNF) and brain derived neurotrophic factor (BDNF) to protect the nigrostriatal system, offers a new opportunity for the treatment of Parkinson’s disease, especially in cases where current small molecule approaches fail to adequately control the symptoms.
For more information on International Stem Cell Corp. and its Parkinson’s disease program, visit www.internationalstemcell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Eric Wolf Joins Dynamics Research Corp. (DRCO)
Leading technology and management company Dynamics Research announced that Eric Wolf has joined the company as vice president and general manager of its Homeland Security Solutions Division.
DRC supports every major component of the Department of Homeland Security, from transportation security to law enforcement and intelligence activities. Homeland security is one of DRC’s key growth markets, and currently represents 13 percent of the company’s annual revenue.
Mr. Wolf will lead the division in its support of homeland security customers in IT policy and planning, enterprise technology architecture, cyber security, information security performance management, and systems engineering.
“Eric is truly a visionary in the government technology marketplace,” said Jim Regan, DRC chairman and CEO. “His executive management experience with leading companies will be a tremendous asset to DRC and our homeland security clients.”
Mr. Wolf’s expertise is perfectly suited for this position, as his resume includes over 25 years of experience in management, technical, and research and development roles within organizations that support federal, civilian, defense, state, and local agencies.
“Being at DRC will allow me to tackle some of the most pressing priorities in homeland security and contribute to programs and operations in areas such as cyber security and border protection that are vital to our nation’s defense,” Mr. Wolf remarked.
Prior to joining DRC, Mr. Wolf spent 11 years with L-3 Communications in a number of leadership positions, including serving as the vice president of an IT services line of business. While in this role, he grew annual sales to almost $70 million dollars.
Mr. Wolf began his career as a software engineer at E-Systems, where he successfully developed an innovative product and associated line of business for three-dimensional visualization and de-confliction of military battle space. He holds a bachelor’s degree from George Washington University School of Engineering and Applied Science, and also completed The General Managers Program at Harvard Business School.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
DRC supports every major component of the Department of Homeland Security, from transportation security to law enforcement and intelligence activities. Homeland security is one of DRC’s key growth markets, and currently represents 13 percent of the company’s annual revenue.
Mr. Wolf will lead the division in its support of homeland security customers in IT policy and planning, enterprise technology architecture, cyber security, information security performance management, and systems engineering.
“Eric is truly a visionary in the government technology marketplace,” said Jim Regan, DRC chairman and CEO. “His executive management experience with leading companies will be a tremendous asset to DRC and our homeland security clients.”
Mr. Wolf’s expertise is perfectly suited for this position, as his resume includes over 25 years of experience in management, technical, and research and development roles within organizations that support federal, civilian, defense, state, and local agencies.
“Being at DRC will allow me to tackle some of the most pressing priorities in homeland security and contribute to programs and operations in areas such as cyber security and border protection that are vital to our nation’s defense,” Mr. Wolf remarked.
Prior to joining DRC, Mr. Wolf spent 11 years with L-3 Communications in a number of leadership positions, including serving as the vice president of an IT services line of business. While in this role, he grew annual sales to almost $70 million dollars.
Mr. Wolf began his career as a software engineer at E-Systems, where he successfully developed an innovative product and associated line of business for three-dimensional visualization and de-confliction of military battle space. He holds a bachelor’s degree from George Washington University School of Engineering and Applied Science, and also completed The General Managers Program at Harvard Business School.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Pazoo, Inc. (PZOO) New Tech Generates First Gross Profit
Yesterday, Pazoo announced that advertising revenue for the company’s websites have generated a dramatic increase over the past week, due to the implementation of new technology. Pazoo.com is generating more daily revenue from advertising sales than it spends on advertising and other expenses incurred to drive traffic to the website.
Pazoo is focused on providing health and wellness information through its website and television, as well as advertising for products and services. The Pazoo.com website acts as a wellness social network that has, according to the company’s press release, “an array of experts delivering vital information to improve and enhance the enjoyment of living a full and enriching life.”
Pazoo describes the technology implemented as being “extremely efficient in delivering ads, placement of the ads, and provides a cascading system of ads on the website.” In addition, the tech allows Pazoo to offer bidding on advertising placement. Gross profit generation for the company means media and social network campaigns will be aggressively ramped up as part of a plan to bring Pazoo to profitability by the end of Q3 2013.
David Cunic, CEO of Pazoo, said “We now have a proven business model that just needs to be scaled up for the overall company to reach profitability. We will continue to take steps to increase and improve the content on the site. Also, we now have plans in place to roll out new mobile app services for not only current information but also for new products, content and services that will be added to www.pazoo.com. Collectively, these new services will first and foremost make Pazoo.com the premier health and wellness community world wide, but also will help us to improve our gross profit margins and attain our ultimate goal of profitability and create shareholder wealth.”
For more information, visit www.pazoo.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Pazoo is focused on providing health and wellness information through its website and television, as well as advertising for products and services. The Pazoo.com website acts as a wellness social network that has, according to the company’s press release, “an array of experts delivering vital information to improve and enhance the enjoyment of living a full and enriching life.”
Pazoo describes the technology implemented as being “extremely efficient in delivering ads, placement of the ads, and provides a cascading system of ads on the website.” In addition, the tech allows Pazoo to offer bidding on advertising placement. Gross profit generation for the company means media and social network campaigns will be aggressively ramped up as part of a plan to bring Pazoo to profitability by the end of Q3 2013.
David Cunic, CEO of Pazoo, said “We now have a proven business model that just needs to be scaled up for the overall company to reach profitability. We will continue to take steps to increase and improve the content on the site. Also, we now have plans in place to roll out new mobile app services for not only current information but also for new products, content and services that will be added to www.pazoo.com. Collectively, these new services will first and foremost make Pazoo.com the premier health and wellness community world wide, but also will help us to improve our gross profit margins and attain our ultimate goal of profitability and create shareholder wealth.”
For more information, visit www.pazoo.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
BrainStorm Cell Therapeutics, Inc. (BCLI) Signs MOU with PRC Clinical to Manage Upcoming Clinical Trial
Leading adult stem cell technology developer BrainStorm Cell Therapeutics announced it has signed a memorandum of understanding (MOU) with San Francisco Bay Area-based contract research organization (CRO) PRC Clinical, in anticipation of BrainCell’s planned Phase II multicenter ALS clinical trial in the U.S.
BrainStorm chose PRC to manage its upcoming trial based on the organization’s comprehensive scope of support services, its experience with both orphan drug trials and neurological disease (specifically ALS), and its cutting-edge monitoring and management technologies.
“PRC Clinical is delighted to have been selected as the CRO for this trial, and we are committed to providing BrainStorm’s clinical development program with the highest quality management and data,” said PRC Clinical President and CEO Curtis Head.
Currently, BrainStorm is conducting a Phase IIa dose-escalating trial involving 12 ALS patients at the Hadassah Medical Center, located in Jerusalem, Israel. BrainStorm plans to launch a Phase II multicenter trial at the end of 2013 at three leading U.S. institutions, pending approval from the FDA.
BrainStorm Cell Therapeutics is a biotechnology company focused on developing first-of-its-kind adult stem cell therapies – derived from autologous bone marrow cells – to treat neurodegenerative diseases. BrainStorm holds the rights to develop and commercialize its NurOwn technology through an exclusive global licensing agreement with Tel Aviv University technology transfer company Ramot.
For more information, visit www.brainstorm-cell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
BrainStorm chose PRC to manage its upcoming trial based on the organization’s comprehensive scope of support services, its experience with both orphan drug trials and neurological disease (specifically ALS), and its cutting-edge monitoring and management technologies.
“PRC Clinical is delighted to have been selected as the CRO for this trial, and we are committed to providing BrainStorm’s clinical development program with the highest quality management and data,” said PRC Clinical President and CEO Curtis Head.
Currently, BrainStorm is conducting a Phase IIa dose-escalating trial involving 12 ALS patients at the Hadassah Medical Center, located in Jerusalem, Israel. BrainStorm plans to launch a Phase II multicenter trial at the end of 2013 at three leading U.S. institutions, pending approval from the FDA.
BrainStorm Cell Therapeutics is a biotechnology company focused on developing first-of-its-kind adult stem cell therapies – derived from autologous bone marrow cells – to treat neurodegenerative diseases. BrainStorm holds the rights to develop and commercialize its NurOwn technology through an exclusive global licensing agreement with Tel Aviv University technology transfer company Ramot.
For more information, visit www.brainstorm-cell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
ScripsAmerica, Inc. (SCRC) Inks Strategic Representation Agreement with DPG Distribution for Launch of RapiMed®
ScripsAmerica, a supplier of pharmaceutical products to a wide range of end users across the health care industry, has entered into a two-year agreement with DPG Distribution (DPG) for the exclusive right to purchase, promote, and resell its RapiMed® over-the-counter products throughout North America, initially starting with its children’s pain reliever and fever reducer.
DPG Distribution offers on a global scale the sales, marketing, and distribution services of targeting high-end retail consumer products. The company calls on some of the largest retail chains in the world such as Wal-Mart, Costco, Target, Walgreens, CVS, and ShopRite. The agreement contains a provision whereby its exclusivity is contingent upon DPG meeting designated sales quotas for RapiMed®.
“ScripsAmerica is extremely proud and pleased to announce this agreement, which we believe has tremendous growth implications for our company and its shareholders,” ScripsAmerica’s CEO, Bob Schneiderman, stated in the press release. “DPG Distribution’s network of clients is not only tremendous in size and quality, but it contains some of the world’s largest retailers who are at the pinnacle of our target market.”
The agreement is expected to maximize ScripsAmerica’s national market opportunities for RapiMed® Children’s Pain Reliever and Fever Reducer, which the company anticipates launching in September.
“We expect this development to have a profound and positive impact on the success of RapiMed®’s product launch as well as its ongoing sales and market penetration,” continued Schneiderman.
Gordon Jones, chief operating officer of DPG Distribution, added, “DPG is very excited to represent RapiMed® in the North American market. RapiMed® has the potential to experience great success penetrating the massive market for children’s pain relievers because of its speed, effectiveness, dosing accuracy and safety. Currently, we believe a very large opportunity exists for a new, superior product like RapiMed® to be introduced and capture significant market share. DPG looks forward to a long and profitable partnership with ScripsAmerica.”
For more information, visit www.ScripsAmerica.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
DPG Distribution offers on a global scale the sales, marketing, and distribution services of targeting high-end retail consumer products. The company calls on some of the largest retail chains in the world such as Wal-Mart, Costco, Target, Walgreens, CVS, and ShopRite. The agreement contains a provision whereby its exclusivity is contingent upon DPG meeting designated sales quotas for RapiMed®.
“ScripsAmerica is extremely proud and pleased to announce this agreement, which we believe has tremendous growth implications for our company and its shareholders,” ScripsAmerica’s CEO, Bob Schneiderman, stated in the press release. “DPG Distribution’s network of clients is not only tremendous in size and quality, but it contains some of the world’s largest retailers who are at the pinnacle of our target market.”
The agreement is expected to maximize ScripsAmerica’s national market opportunities for RapiMed® Children’s Pain Reliever and Fever Reducer, which the company anticipates launching in September.
“We expect this development to have a profound and positive impact on the success of RapiMed®’s product launch as well as its ongoing sales and market penetration,” continued Schneiderman.
Gordon Jones, chief operating officer of DPG Distribution, added, “DPG is very excited to represent RapiMed® in the North American market. RapiMed® has the potential to experience great success penetrating the massive market for children’s pain relievers because of its speed, effectiveness, dosing accuracy and safety. Currently, we believe a very large opportunity exists for a new, superior product like RapiMed® to be introduced and capture significant market share. DPG looks forward to a long and profitable partnership with ScripsAmerica.”
For more information, visit www.ScripsAmerica.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Loans4Less.com, Inc. (LFLS) Continues to Grow with Nationally Expanding Housing Market
After years of discouraging news on the housing front, the housing recovery is now well under way. With it, however, have come a new set of challenges and concerns. Chief among them is the fear that the market, at least in some parts of the country, is entering a new bubble phase.
Bubbles have always been part of the real estate landscape, but have traditionally been highly localized and were simply accepted as minor, if inevitable, fluctuations. Since the recent real estate and financial collapse, however, the word has taken on a new gravitas. Fast rising housing prices, primarily in the West, have understandably provoked a certain amount of anxiety.
Housing prices in parts of California have jumped over 30% in the past year. Nevertheless there is a major difference in the dynamics behind the increases. Unlike previously, where loose credit created a highly unstable underpinning, and prices were supported almost entirely by speculative greed, today’s market represents more of a bounce back from record lows, based upon pent-up demand and low inventories. Credit is much tighter now, creating a firmer economic foundation and reducing chances of a sudden collapse.
Loans4Less.com, a California based online mortgage broker and real estate information platform, is perfectly aligned with the more conservative approach to credit, in addition to the continuing growth in the nationwide real estate market and the influx of new buyers it represents. The company focuses on “A” paper conforming loans, plus has gone to great lengths to create a comprehensive online user resource, attracting both buyers and sellers seeking up-to-date real estate and mortgage information. The goal is to become a national real estate platform, attractive to partnerships, and the company’s revenue growth continues to support its strategy.
For more information, visit www.Loans4Less.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Bubbles have always been part of the real estate landscape, but have traditionally been highly localized and were simply accepted as minor, if inevitable, fluctuations. Since the recent real estate and financial collapse, however, the word has taken on a new gravitas. Fast rising housing prices, primarily in the West, have understandably provoked a certain amount of anxiety.
Housing prices in parts of California have jumped over 30% in the past year. Nevertheless there is a major difference in the dynamics behind the increases. Unlike previously, where loose credit created a highly unstable underpinning, and prices were supported almost entirely by speculative greed, today’s market represents more of a bounce back from record lows, based upon pent-up demand and low inventories. Credit is much tighter now, creating a firmer economic foundation and reducing chances of a sudden collapse.
Loans4Less.com, a California based online mortgage broker and real estate information platform, is perfectly aligned with the more conservative approach to credit, in addition to the continuing growth in the nationwide real estate market and the influx of new buyers it represents. The company focuses on “A” paper conforming loans, plus has gone to great lengths to create a comprehensive online user resource, attracting both buyers and sellers seeking up-to-date real estate and mortgage information. The goal is to become a national real estate platform, attractive to partnerships, and the company’s revenue growth continues to support its strategy.
For more information, visit www.Loans4Less.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Wednesday, June 26, 2013
Top Three Things You Need to Know about the OTC Marketplace
Whether you’re a fast-fingered day trader or a long-hold Joe, if you play the markets you’re a risk taker. You’ve found what works, what doesn’t; polished your due diligence process to determine who to follow, who to run from; and have discovered the high potential niche markets in the OTC realm. But when it comes to the ever changing OTCBB landscape, are you keeping the pace or do you still have a few lingering questions?
We’ve compiled a handful of some of the most important topics regarding the OTC marketplace.
What happened to “.OB” and “.PK”?
The ticker extensions “.OB” and “.PK” were originally tacked onto the end of ticker symbols as an identifier of securities quoted on the OTC Bulletin Board and Pinksheets. As you may have noticed, however, the handy little flags are no more. The majority of Web sites, including Yahoo Finance and Google, no longer recognize these ticker extensions as they are not part of the security symbols formally issued by the Financial Industry Regulatory Authority (FINRA).
Why are big-name financial sites inconsistent with the OTC market data and marketplace designation they provide?
Because the majority of financial Web sites receive data from various sources, often time the data displayed is outdated or flat-out incorrect. Yahoo and Google both display delayed last sale and trade data for most publicly traded companies, though bid and ask price quotes are reserved only for companies listed on NASDAQ or NYSE.
If you’re looking for real-time best bid and ask prices and correct marketplace designation for OTCQX, OTCQB, and OTC Pink companies, www.OTCMarkets.com is your honey hole. It’s important to note that while trading no longer occurs on the OTCBB, due to systemic coding, a company may be labeled incorrectly as OTCBB if an unpriced quote still remains on the OTCBB.
Level 2 Quotes refer to all broker-dealer bid/ask quote prices and size in a security and provide transparency for the company by displaying a full list of active market makers vs. incomplete or no pricing on the OTCBB. Companies can sponsor Real-time Level 2 Quotes for all investors to view on their www.OTCMarkets.com quote page as well as on their own corporate Investor Relations page. Here’s where you benefit trading OTC: while traditional stock exchanges charge investors a fee to access Level 2 Quote data, OTCQB companies can make this information widely available at no additional charge to investors.
Speaking of … what exactly does OTCQX, OTCQB, OTCBB, and OTC Pink mean and where did they come from?
OTC Markets Group established separate marketplaces to provide clarity in the investment process. Per this model, OTC securities are categorized into three tiered marketplaces based on the quality and quantity of information the company provides to the public.
OTCQX is the top rank for OTC companies that want to differentiate themselves from riskier investments, shells, distressed, and speculative calls. Companies listed on this marketplace must meet certain financial standards and ongoing disclosure requirements. Inclusion to the OTCQX starts with the company submitting an application for eligibility followed by management background check and the appointment of an approved third-party attorney or investment bank as a sponsor.
Companies upgrade to OTCQX to validate the strength of their financials and reputation of their management teams, as well as to create greater recognition and credibility in the investment community.
For companies pursuing NYSE or NASDAQ listing but lacking the stricter exchange qualifications, OTCQX provides a suitable alternative for creating brand awareness and attracting investors.
The OTCQB marketplace replaces the FINRA-operated OTCBB. OTCQB is a venture-stage, broker-dealer driven marketplace for unlisted SEC and banking reporting securities that can prove they are current in their disclosures to their respective U.S. regulators. There are no minimal financial standards or business operation requirements for inclusion to the OTCQB, which means the marketplace also includes shells, penny stocks, and financially distressed companies.
OTC Pink is a broker-dealer driven marketplace and home to the wide array of equity securities that are not U.S. reporting. OTC Pink companies are further broken down into sub-tiers based on the level of information that they provide to the public.
For more information, visit www.otcmarkets.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
We’ve compiled a handful of some of the most important topics regarding the OTC marketplace.
What happened to “.OB” and “.PK”?
The ticker extensions “.OB” and “.PK” were originally tacked onto the end of ticker symbols as an identifier of securities quoted on the OTC Bulletin Board and Pinksheets. As you may have noticed, however, the handy little flags are no more. The majority of Web sites, including Yahoo Finance and Google, no longer recognize these ticker extensions as they are not part of the security symbols formally issued by the Financial Industry Regulatory Authority (FINRA).
Why are big-name financial sites inconsistent with the OTC market data and marketplace designation they provide?
Because the majority of financial Web sites receive data from various sources, often time the data displayed is outdated or flat-out incorrect. Yahoo and Google both display delayed last sale and trade data for most publicly traded companies, though bid and ask price quotes are reserved only for companies listed on NASDAQ or NYSE.
If you’re looking for real-time best bid and ask prices and correct marketplace designation for OTCQX, OTCQB, and OTC Pink companies, www.OTCMarkets.com is your honey hole. It’s important to note that while trading no longer occurs on the OTCBB, due to systemic coding, a company may be labeled incorrectly as OTCBB if an unpriced quote still remains on the OTCBB.
Level 2 Quotes refer to all broker-dealer bid/ask quote prices and size in a security and provide transparency for the company by displaying a full list of active market makers vs. incomplete or no pricing on the OTCBB. Companies can sponsor Real-time Level 2 Quotes for all investors to view on their www.OTCMarkets.com quote page as well as on their own corporate Investor Relations page. Here’s where you benefit trading OTC: while traditional stock exchanges charge investors a fee to access Level 2 Quote data, OTCQB companies can make this information widely available at no additional charge to investors.
Speaking of … what exactly does OTCQX, OTCQB, OTCBB, and OTC Pink mean and where did they come from?
OTC Markets Group established separate marketplaces to provide clarity in the investment process. Per this model, OTC securities are categorized into three tiered marketplaces based on the quality and quantity of information the company provides to the public.
OTCQX is the top rank for OTC companies that want to differentiate themselves from riskier investments, shells, distressed, and speculative calls. Companies listed on this marketplace must meet certain financial standards and ongoing disclosure requirements. Inclusion to the OTCQX starts with the company submitting an application for eligibility followed by management background check and the appointment of an approved third-party attorney or investment bank as a sponsor.
Companies upgrade to OTCQX to validate the strength of their financials and reputation of their management teams, as well as to create greater recognition and credibility in the investment community.
For companies pursuing NYSE or NASDAQ listing but lacking the stricter exchange qualifications, OTCQX provides a suitable alternative for creating brand awareness and attracting investors.
The OTCQB marketplace replaces the FINRA-operated OTCBB. OTCQB is a venture-stage, broker-dealer driven marketplace for unlisted SEC and banking reporting securities that can prove they are current in their disclosures to their respective U.S. regulators. There are no minimal financial standards or business operation requirements for inclusion to the OTCQB, which means the marketplace also includes shells, penny stocks, and financially distressed companies.
OTC Pink is a broker-dealer driven marketplace and home to the wide array of equity securities that are not U.S. reporting. OTC Pink companies are further broken down into sub-tiers based on the level of information that they provide to the public.
For more information, visit www.otcmarkets.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
AudioEye, Inc. (AEYE) Automated Publishing Technology Secures Territory via Partnership with Government Sales Specialists
AudioEye, the developers of a truly revolutionary, patented voice infrastructure technology and content publication/distribution software architecture that enables accessible real-time Internet distribution to any connected device irrespective of format, made a big leap today in their ongoing expansion into lucrative federal, state, and local government markets, as the report comes in of a partnership with government sales giant, Government Sales Specialists (GSS).
These are the guys to talk to if you want to start upping your game in the government end of the sales pool and GSS has proved indispensible for many small tech companies looking to improve traction in this otherwise difficult to break into area. CEO of GSS, Mark Hogan, is the man who took BEA Government Systems from a $2M penny ante to $150M in business, providing tech to federal clients with such proficiency that eventually GSS was created out of the top executive shooters he could assemble in the federal sales game. Leveraging a matrix that stretches down into the C-level of the civilian, defense, and intelligence community, GSS is able to open doors for tech developers using every advantage of the vast network of inside sales reps, partners, and researchers at their disposal.
Big news for AudioEye, whose three distinct product groups, AudioEye Mobile, AudioEye Internet, and AudioEye Technology Licensing, provide precisely the kind of solutions that will help meet current mandates on federal agencies requiring them to migrate websites and data into a format that is somehow accessible to people with disabilities. AudioEye’s relentless drive to make data accessible with cutting-edge audio internet capabilities, as well as service offerings that exploit the company’s cloud-based SaaS technology, places them ahead of the pack when it comes to capturing territory in what Hogan describes as an enormous federal environment of rising, unmet demand.
It should be noted that AudioEye is no stranger to working hand-in-hand with agencies in both the public and private sphere either. Many of the company’s partners are characterized as having the most challenging, as well as the most complex of business, industrial, intelligence, and security concerns. Having performed remarkably in this capacity thus far, the U.S. owned and operated, Tucson-based AEYE is an ideal candidate for this sort of government work and should find fast favor with federal agencies seeking to upgrade their digital accessibility.
CEO of AEYE, Nathaniel Bradley, noted the impressive track record established thus far by the company with partners having deep ties within government agencies and called the new partnership a way of accelerating their current momentum. This partnership will allow the company’s innovative technology to more rapidly reach key decision-makers who are generally unaware of how the AEYE technology can easily solve their pressing needs. This move really puts AEYE on the map and will help foster the kinds of long-terms relationships that can support further R&D, leading to even greater prominence in voice infrastructure technology.
Much of the baseline impetus for this market comes directly out of 21st Century Communications Act (signed Oct 2010) compliance and it spells a bright future for AEYE as agencies scramble in response, generating unprecedented demand upon which this partnership will no doubt thrive. The company’s Audio Internet product recently won the Gold Medal at this year’s Edison Awards and has been issued 5 patents here in the United States (with over 100 issued claimed inventions and ongoing prosecution of 15 patents pending at home and abroad). AEYE will be putting 50 of their best people into the loop on this one, grabbing sales associates who specifically have the kind of extensive government experience and marked success rates that will ensure continued momentum.
If you know how government agencies work, there is going to be a real crunch coming as pressures rise to meet accessibility demands at the last minute, and AEYE plans to be there to capture the maximum force possible from that move and its sustained impact.
For more info on AudioEye, visit www.AudioEye.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
These are the guys to talk to if you want to start upping your game in the government end of the sales pool and GSS has proved indispensible for many small tech companies looking to improve traction in this otherwise difficult to break into area. CEO of GSS, Mark Hogan, is the man who took BEA Government Systems from a $2M penny ante to $150M in business, providing tech to federal clients with such proficiency that eventually GSS was created out of the top executive shooters he could assemble in the federal sales game. Leveraging a matrix that stretches down into the C-level of the civilian, defense, and intelligence community, GSS is able to open doors for tech developers using every advantage of the vast network of inside sales reps, partners, and researchers at their disposal.
Big news for AudioEye, whose three distinct product groups, AudioEye Mobile, AudioEye Internet, and AudioEye Technology Licensing, provide precisely the kind of solutions that will help meet current mandates on federal agencies requiring them to migrate websites and data into a format that is somehow accessible to people with disabilities. AudioEye’s relentless drive to make data accessible with cutting-edge audio internet capabilities, as well as service offerings that exploit the company’s cloud-based SaaS technology, places them ahead of the pack when it comes to capturing territory in what Hogan describes as an enormous federal environment of rising, unmet demand.
It should be noted that AudioEye is no stranger to working hand-in-hand with agencies in both the public and private sphere either. Many of the company’s partners are characterized as having the most challenging, as well as the most complex of business, industrial, intelligence, and security concerns. Having performed remarkably in this capacity thus far, the U.S. owned and operated, Tucson-based AEYE is an ideal candidate for this sort of government work and should find fast favor with federal agencies seeking to upgrade their digital accessibility.
CEO of AEYE, Nathaniel Bradley, noted the impressive track record established thus far by the company with partners having deep ties within government agencies and called the new partnership a way of accelerating their current momentum. This partnership will allow the company’s innovative technology to more rapidly reach key decision-makers who are generally unaware of how the AEYE technology can easily solve their pressing needs. This move really puts AEYE on the map and will help foster the kinds of long-terms relationships that can support further R&D, leading to even greater prominence in voice infrastructure technology.
Much of the baseline impetus for this market comes directly out of 21st Century Communications Act (signed Oct 2010) compliance and it spells a bright future for AEYE as agencies scramble in response, generating unprecedented demand upon which this partnership will no doubt thrive. The company’s Audio Internet product recently won the Gold Medal at this year’s Edison Awards and has been issued 5 patents here in the United States (with over 100 issued claimed inventions and ongoing prosecution of 15 patents pending at home and abroad). AEYE will be putting 50 of their best people into the loop on this one, grabbing sales associates who specifically have the kind of extensive government experience and marked success rates that will ensure continued momentum.
If you know how government agencies work, there is going to be a real crunch coming as pressures rise to meet accessibility demands at the last minute, and AEYE plans to be there to capture the maximum force possible from that move and its sustained impact.
For more info on AudioEye, visit www.AudioEye.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
GlobalWise Investments, Inc. (GWIV) and the Communication Revolution
The story of civilization is largely the story of communication, of how information has been passed from person to person, or group to group. From the development of complex verbal and then written language, to hand-printed and then press-printed books, to the telegraph and telephone, not forgetting pictures, photographs, and moving pictures, and finally radio and television, it all seems to be prologue for what is happening today. We still have language and books, telephones, radio, and television, but the fact is that the vast digital network we know as the Internet is becoming the dominant backbone of communication, and is gradually replacing all of the forms that have come before.
Today we routinely talk and message over the Internet, and use it to send and publish pictures and videos. Books, a form that has been around since the invention of papyrus, are now transmitted and displayed digitally. Telephone communication is increasingly VoIP or through services such as Skype. Radio and television is more and more likely to be Internet based, with some families doing the greatest part of their television viewing using services like Netflix. Even commercial theaters are now downloading and displaying movies and other content digitally.
A major part of this communication revolution is cloud technology, the ability to have data stored and processed remotely, greatly increasing the functionality of small mobile devices. By giving distant users instant access to enormous sets of centralized data and processing power, cloud technology gives the Internet a new dimension, opening a world of new possibilities.
GlobalWise Investments, through its Intellinetics subsidiary, is an example of the power of the cloud. The company provides advanced ECM (Enterprise Content Management) capabilities to both large and small organizations, solutions that allow controlled access to large volumes of documents from remote sites via mobile devices. Using their system, an authorized employee can instantly access and process huge stores of documents on a 24/7 basis from anywhere in the world.
For more information visit www.globalwiseinvestments.com or www.intellinetics.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Today we routinely talk and message over the Internet, and use it to send and publish pictures and videos. Books, a form that has been around since the invention of papyrus, are now transmitted and displayed digitally. Telephone communication is increasingly VoIP or through services such as Skype. Radio and television is more and more likely to be Internet based, with some families doing the greatest part of their television viewing using services like Netflix. Even commercial theaters are now downloading and displaying movies and other content digitally.
A major part of this communication revolution is cloud technology, the ability to have data stored and processed remotely, greatly increasing the functionality of small mobile devices. By giving distant users instant access to enormous sets of centralized data and processing power, cloud technology gives the Internet a new dimension, opening a world of new possibilities.
GlobalWise Investments, through its Intellinetics subsidiary, is an example of the power of the cloud. The company provides advanced ECM (Enterprise Content Management) capabilities to both large and small organizations, solutions that allow controlled access to large volumes of documents from remote sites via mobile devices. Using their system, an authorized employee can instantly access and process huge stores of documents on a 24/7 basis from anywhere in the world.
For more information visit www.globalwiseinvestments.com or www.intellinetics.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Premier Biomedical, Inc. (BIEL) Posts Favorable Phase 1 Clinical Trial for Breast Cancer Treatment
Premier Biomedical has released the results of a completed phase 1 mouse testing of its breast cancer therapy, with results demonstrating the methodology’s ability to outperform chemotherapy with a much lower mortality rate, smaller tumor volume, and increased subject weight gain recorded 19 days after first treatment.
Twenty-five days into the study, the mice administered Premier Biomedical’s treatment experienced a 100 percent survival rate without encountering a single cancer-related fatality. This is compared to a mortality rate of nearly one-third of the mice subjected to chemotherapy.
In addition, the tumors of the mice given Premier Biomedical’s treatment shrunk in size in the days following the application while the size of the tumors within the mice subjected to chemotherapy rapidly grew throughout the duration of the study.
In animal cancer studies, greater weight of the subject typically indicates greater health. Premier Biomedical reports that the mice that received its treatment gained weight over the course of the study and consistently had a greater weight than both the untreated mice and the mice which were subjected to chemotherapy.
“Every doctor has seen a patient whose mortality was undoubtedly certain, yet miraculously fought against all odds and lived. In these mice test results, an unlikely biological process appears to occur in which the immune system is enabled by the treatment and fights off and kills the cancer. It is this process that we believe we are replicating in Premier Biomedical’s anti-cancer methodologies,” Mitchell S. Felder, M.D. inventor of the core technology, stated in the press release.
William A. Hartman, CEO and president of Premier Biomedical, emphasized the importance of the phase 1 results and noted that while the treatment is in its early stages, it has high potential in the fight against cancer.
“It is an understatement to say that the results produced here are remarkable,” Hartman said. “Premier Biomedical’s methodology is undoubtedly in its infancy. But with the right funding, support from our organizational partners and from the compassionate cancer community, we have good reason to believe that we can cure breast cancer. Just as significantly, we have good reason to believe that we may be able to finally offer a more effective treatment option that saves patients from the harm of chemotherapy, which remains the best current and available treatment today.”
For more information, visit www.premierbiomedicalinc.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Twenty-five days into the study, the mice administered Premier Biomedical’s treatment experienced a 100 percent survival rate without encountering a single cancer-related fatality. This is compared to a mortality rate of nearly one-third of the mice subjected to chemotherapy.
In addition, the tumors of the mice given Premier Biomedical’s treatment shrunk in size in the days following the application while the size of the tumors within the mice subjected to chemotherapy rapidly grew throughout the duration of the study.
In animal cancer studies, greater weight of the subject typically indicates greater health. Premier Biomedical reports that the mice that received its treatment gained weight over the course of the study and consistently had a greater weight than both the untreated mice and the mice which were subjected to chemotherapy.
“Every doctor has seen a patient whose mortality was undoubtedly certain, yet miraculously fought against all odds and lived. In these mice test results, an unlikely biological process appears to occur in which the immune system is enabled by the treatment and fights off and kills the cancer. It is this process that we believe we are replicating in Premier Biomedical’s anti-cancer methodologies,” Mitchell S. Felder, M.D. inventor of the core technology, stated in the press release.
William A. Hartman, CEO and president of Premier Biomedical, emphasized the importance of the phase 1 results and noted that while the treatment is in its early stages, it has high potential in the fight against cancer.
“It is an understatement to say that the results produced here are remarkable,” Hartman said. “Premier Biomedical’s methodology is undoubtedly in its infancy. But with the right funding, support from our organizational partners and from the compassionate cancer community, we have good reason to believe that we can cure breast cancer. Just as significantly, we have good reason to believe that we may be able to finally offer a more effective treatment option that saves patients from the harm of chemotherapy, which remains the best current and available treatment today.”
For more information, visit www.premierbiomedicalinc.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
ISC8, Inc. (ISCI) Signs Agreement with a Leading UK Mobile Operator
ISC8, a provider of intelligent cyber security solutions, announced today the entrance into a one-year support agreement with a prominent UK mobile operator’s product, Cyber NetControl™.
Under framework services, support, and license agreement, ISC8 Secure® has been recruited to supply, install, implement, maintain, and support the Cyber NetControl System, which will provide content filtering for millions of subscribers. A high performance, carrier-grade platform, Cyber NetControl allows service providers and enterprises alike to protect users from accessing inappropriate content on a network-wide or per-user basis. The platform combines web filtering and traffic enforcement for comprehensive as well as accurate policy enforcement.
“The selection of ISC8′s technology demonstrates the leading edge nature of the product’s capabilities in support of the pending video classification framework for mobile content and web sites being proposed by the British Board of Film Classification (BBFC),” commented Bill Joll, president and CEO of ISC8. “ISC8′s experience in web-filtering and traffic control will help provide the operators with tools to offer their consumers a safer, more secure Internet experience.”
The BBFC is known within the UK video industry to provide a distinct content labeling system of age-rating for video content supplied online. The BBFC has digitally classified an astounding 200,000 titles providing users with access to labeling and content information for a large portfolio of films and television programs which are available online through video-on-demand, digital rental, streaming, mobile, and connected TV.
For more information about ISC8, visit www.isc8.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Under framework services, support, and license agreement, ISC8 Secure® has been recruited to supply, install, implement, maintain, and support the Cyber NetControl System, which will provide content filtering for millions of subscribers. A high performance, carrier-grade platform, Cyber NetControl allows service providers and enterprises alike to protect users from accessing inappropriate content on a network-wide or per-user basis. The platform combines web filtering and traffic enforcement for comprehensive as well as accurate policy enforcement.
“The selection of ISC8′s technology demonstrates the leading edge nature of the product’s capabilities in support of the pending video classification framework for mobile content and web sites being proposed by the British Board of Film Classification (BBFC),” commented Bill Joll, president and CEO of ISC8. “ISC8′s experience in web-filtering and traffic control will help provide the operators with tools to offer their consumers a safer, more secure Internet experience.”
The BBFC is known within the UK video industry to provide a distinct content labeling system of age-rating for video content supplied online. The BBFC has digitally classified an astounding 200,000 titles providing users with access to labeling and content information for a large portfolio of films and television programs which are available online through video-on-demand, digital rental, streaming, mobile, and connected TV.
For more information about ISC8, visit www.isc8.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Raptor Resources Holdings Inc. (RRHI) Releases 1st Edition of RaptorNews
Raptor Resources Holdings today posted the 1st edition of RaptorNews, an online publication that provides the latest company news. This issue announces the engagement of ASCON Africa’s consulting services to perform a Dodge Mine Validation Study to substantiate the barite and limestone reserves based on the 1966 JCI core drilling/ADIT tunnel project.
Based on ASCON Africa’s report, 411K tons of barite and 531K tons of limestone reserves were authenticated. The focus of the study was on Dodge Hill #1, which represents only about 7% of the entire surface area of Dodge Mine. Assuming general prices for barite at $150/ton and limestone at $33/ton, respectively, this section of Dodge Mine alone represents a market value of $61.5M (barite) and $17.5M (limestone) for a total of $79M. For more details as well as visuals, read the entire RaptorNews issue at Raptor Resources Holding’s Web site.
Future company announcements will be made first via the Web site before a press release is distributed. Investors will always get the latest news and information at www.raptorresourcesholdings.com/corporate-briefing-2.
For more information on Raptor Resources, visit www.raptorresourcesholdings.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Based on ASCON Africa’s report, 411K tons of barite and 531K tons of limestone reserves were authenticated. The focus of the study was on Dodge Hill #1, which represents only about 7% of the entire surface area of Dodge Mine. Assuming general prices for barite at $150/ton and limestone at $33/ton, respectively, this section of Dodge Mine alone represents a market value of $61.5M (barite) and $17.5M (limestone) for a total of $79M. For more details as well as visuals, read the entire RaptorNews issue at Raptor Resources Holding’s Web site.
Future company announcements will be made first via the Web site before a press release is distributed. Investors will always get the latest news and information at www.raptorresourcesholdings.com/corporate-briefing-2.
For more information on Raptor Resources, visit www.raptorresourcesholdings.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
BIO-key International, Inc. (BKYI) TruDonor Fingerprint Identification System Implemented by Suncoast Communities Blood Bank
BIO-key International has announced that Suncoast Communities Blood Bank (SCBB) has successfully launched the company’s TruDonor donor search and identification solution, providing the security and convenience of automated positive donor identification at all SCBB donor centers. SCBB received a grant from the Venice Endowment Fund through the Gulf Coast Community Foundation in support of purchasing the new fingerprint donor identification system.
The new donor identification system from BIO-key will allow SCBB to more efficiently search for and positively identify blood donors, at the same time enabling the detection and prevention of duplicate donor records, the protection of donor privacy, and the elimination of errors associated with manual registration. A certified green business, SCBB provides state-of-the-art transfusion medical services and serves thousands of patients each year through its support of dozens of hospitals and clinics. Implementing BIO-key’s innovation will not only ensure a safer blood supply, but it will also allow SCBB to continue doing its part to protect and preserve the environment through reducing the use of paper products.
“We are excited to add Suncoast Communities Blood Banks to our growing family of blood center customers,” said BIO-key Vice President of Strategy and Business Development Jim Sullivan. “By utilizing BIO-key to automate donor enrollment and check-in, Suncoast will detect duplicate donor records before they are created while reducing donor check-in to a two-second process at the registration desk. The reaction of donors and staff has been incredibly positive, as increased donor convenience benefits the entire organization. Instead of trying to determine who a donor is, staff are free to focus on making the donor’s experience a more positive one.”
BIO-key’s technology is currently being utilized by six blood centers, and the company has issued more than 3 million donor ID licenses. The implementation by SCBB is a further indication that the company’s finger biometric technology is becoming the preferred authentication and identification option for patient, donor, and customer access.
“We can say with confidence that the BIO-key family of blood centers, transfusion facilities and hospitals will continue to grow, as the security and convenience provided by our biometrics in eliminating cards and passwords enhances the identification experience for donors and staff,” said BIO-key CEO Mike DePasquale.
For more information, visit www.bio-key.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
The new donor identification system from BIO-key will allow SCBB to more efficiently search for and positively identify blood donors, at the same time enabling the detection and prevention of duplicate donor records, the protection of donor privacy, and the elimination of errors associated with manual registration. A certified green business, SCBB provides state-of-the-art transfusion medical services and serves thousands of patients each year through its support of dozens of hospitals and clinics. Implementing BIO-key’s innovation will not only ensure a safer blood supply, but it will also allow SCBB to continue doing its part to protect and preserve the environment through reducing the use of paper products.
“We are excited to add Suncoast Communities Blood Banks to our growing family of blood center customers,” said BIO-key Vice President of Strategy and Business Development Jim Sullivan. “By utilizing BIO-key to automate donor enrollment and check-in, Suncoast will detect duplicate donor records before they are created while reducing donor check-in to a two-second process at the registration desk. The reaction of donors and staff has been incredibly positive, as increased donor convenience benefits the entire organization. Instead of trying to determine who a donor is, staff are free to focus on making the donor’s experience a more positive one.”
BIO-key’s technology is currently being utilized by six blood centers, and the company has issued more than 3 million donor ID licenses. The implementation by SCBB is a further indication that the company’s finger biometric technology is becoming the preferred authentication and identification option for patient, donor, and customer access.
“We can say with confidence that the BIO-key family of blood centers, transfusion facilities and hospitals will continue to grow, as the security and convenience provided by our biometrics in eliminating cards and passwords enhances the identification experience for donors and staff,” said BIO-key CEO Mike DePasquale.
For more information, visit www.bio-key.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Frozen Food Gift Group, Inc. (FROZ) Serves Diverse and Growing Client Base
Frozen Food Gift Group, through the company’s wholly owned subsidiary, Miami Ice Machine Company (MIMCO), is a leading provider of ice machines and refrigeration equipment, serving a variety of industries primarily in Florida, plus exporting to the Caribbean, Central and South America. As machine manufacturers, MIMCO has developed a full lineup of ice machines for business, no matter what the application, including the following:
• Supermarkets
• Convenience Stores
• Health Care Centers
• Cruise Ships
• Restaurants
• Bars & Night Clubs
• Maritime Vessels
• Special Events
MIMCO has manufactured and installed more than 100,000 pieces of equipment for its customers, and is known for producing top-of-the-line innovative and highly reliable ice equipment, offered for sale as well as for long-term and short-term rental. Since they manufacture their own ice machines, they are able to offer significant discounts, as well as service their machines with factory-certified technicians versus outsourcing. The company services other makes and models in addition to their own equipment, and now even provides general residential and commercial electrical, plumbing, and HVAC contracting services.
Besides their own famous ice machines, the company offers a full range of refrigeration equipment from top name manufacturers, including walk-in refrigerators and freezers, reach drink cabinets, deli counters, and much more.
For more information, visit www.MiamiIceMachine.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
• Supermarkets
• Convenience Stores
• Health Care Centers
• Cruise Ships
• Restaurants
• Bars & Night Clubs
• Maritime Vessels
• Special Events
MIMCO has manufactured and installed more than 100,000 pieces of equipment for its customers, and is known for producing top-of-the-line innovative and highly reliable ice equipment, offered for sale as well as for long-term and short-term rental. Since they manufacture their own ice machines, they are able to offer significant discounts, as well as service their machines with factory-certified technicians versus outsourcing. The company services other makes and models in addition to their own equipment, and now even provides general residential and commercial electrical, plumbing, and HVAC contracting services.
Besides their own famous ice machines, the company offers a full range of refrigeration equipment from top name manufacturers, including walk-in refrigerators and freezers, reach drink cabinets, deli counters, and much more.
For more information, visit www.MiamiIceMachine.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Tuesday, June 25, 2013
DoMark International, Inc. (DOMK) Successfully Targets Critical Mobile Charging Market
DoMark International seeks out companies offering profitable technologies with proven markets. It’s a term that perfectly describes the company’s primary subsidiary, SolaWerks, serving one of the modern world’s most widespread and expanding markets, mobile devices. SolaWerks sells their own proprietary and superior technology for charging some of the most popular mobile devices. Their systems incorporate a unique system for capturing invisible infrared radiation, allowing Apple and Samsung devices to be charged both indoors and outdoors.
Anyone who questions the importance of mobile device charging need only reflect on events immediately following Superstorm Sandy. For days after the storm, restaurants all over the New York area saw long lines of people, not looking for food but rather electricity. After losing power for so long, they were desperate to charge their mobile phones and tablets. The city is now even putting in place public charging stations to better address this growing need.
The fact is that richly functional mobile communication is increasingly considered a necessity for virtually every corner of society, all of it powered by battery technology requiring a flexible and robust charging resource. The company has already received 158,000 orders for their new IRCharger case for Apple iPhones and Samsung Galaxy smartphones, all prior to their August launch. Given the retail pricing structure for the products, it represents a huge revenue kick for both SolaWerks and DoMark.
For more information, visit www.DoMarkIntl.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
DoMark International seeks out companies offering profitable technologies with proven markets. It’s a term that perfectly describes the company’s primary subsidiary, SolaWerks, serving one of the modern world’s most widespread and expanding markets, mobile devices. SolaWerks sells their own proprietary and superior technology for charging some of the most popular mobile devices. Their systems incorporate a unique system for capturing invisible infrared radiation, allowing Apple and Samsung devices to be charged both indoors and outdoors.
Anyone who questions the importance of mobile device charging need only reflect on events immediately following Superstorm Sandy. For days after the storm, restaurants all over the New York area saw long lines of people, not looking for food but rather electricity. After losing power for so long, they were desperate to charge their mobile phones and tablets. The city is now even putting in place public charging stations to better address this growing need.
The fact is that richly functional mobile communication is increasingly considered a necessity for virtually every corner of society, all of it powered by battery technology requiring a flexible and robust charging resource. The company has already received 158,000 orders for their new IRCharger case for Apple iPhones and Samsung Galaxy smartphones, all prior to their August launch. Given the retail pricing structure for the products, it represents a huge revenue kick for both SolaWerks and DoMark.
For more information, visit www.DoMarkIntl.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Anyone who questions the importance of mobile device charging need only reflect on events immediately following Superstorm Sandy. For days after the storm, restaurants all over the New York area saw long lines of people, not looking for food but rather electricity. After losing power for so long, they were desperate to charge their mobile phones and tablets. The city is now even putting in place public charging stations to better address this growing need.
The fact is that richly functional mobile communication is increasingly considered a necessity for virtually every corner of society, all of it powered by battery technology requiring a flexible and robust charging resource. The company has already received 158,000 orders for their new IRCharger case for Apple iPhones and Samsung Galaxy smartphones, all prior to their August launch. Given the retail pricing structure for the products, it represents a huge revenue kick for both SolaWerks and DoMark.
For more information, visit www.DoMarkIntl.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
DoMark International seeks out companies offering profitable technologies with proven markets. It’s a term that perfectly describes the company’s primary subsidiary, SolaWerks, serving one of the modern world’s most widespread and expanding markets, mobile devices. SolaWerks sells their own proprietary and superior technology for charging some of the most popular mobile devices. Their systems incorporate a unique system for capturing invisible infrared radiation, allowing Apple and Samsung devices to be charged both indoors and outdoors.
Anyone who questions the importance of mobile device charging need only reflect on events immediately following Superstorm Sandy. For days after the storm, restaurants all over the New York area saw long lines of people, not looking for food but rather electricity. After losing power for so long, they were desperate to charge their mobile phones and tablets. The city is now even putting in place public charging stations to better address this growing need.
The fact is that richly functional mobile communication is increasingly considered a necessity for virtually every corner of society, all of it powered by battery technology requiring a flexible and robust charging resource. The company has already received 158,000 orders for their new IRCharger case for Apple iPhones and Samsung Galaxy smartphones, all prior to their August launch. Given the retail pricing structure for the products, it represents a huge revenue kick for both SolaWerks and DoMark.
For more information, visit www.DoMarkIntl.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Cardium Therapeutics, Inc. (CXM) Positioned to Advance Leading Products with Experienced Leadership at the Helm
Cardium Therapeutics has established a diversified portfolio of medical products with large market potential. Armed with a capital-efficient, asset-based business strategy, the company is positioned to continue to build its portfolio with balanced risk/return opportunities in a variety of markets and is working to secure approval for marketing and sale in South Korea and the European Union.
Company CEO Christopher J. Reinhard founded the company in December 2003, backed by nearly 15 years of focus on the commercial development of cardiovascular growth factor therapeutics.
Under Reinhard’s leadership, Cardium is working to advance its ASPIRE Generx® clinical study at major medical centers in Russia. The company is also seeking clinical development and commercialization partners for Generx® in countries such as India, China and Brazil.
The Generx® product candidate is a minimally invasive DNA-based angiogenic growth factor therapy in development for the treatment of patients with advanced coronary artery disease. The product is being developed for international markets as an alternative treatment for patients who may not have access to surgical revascularization procedures such as coronary artery bypass surgery and angioplasty/stents.
Cardium’s Excellagen® is a syringe-based collagen gel designed to speed the growth of granulation tissue and to trigger the wound healing process. The product is FDA-cleared as treatment of neuropathic and diabetic foot ulcers, pressure ulcers, venous ulcers, surgical wounds, and other dermal wounds. Cardium is seeking commercialization partners for the marketing and sale of the product both domestically and internationally.
Cardium’s To Go Brands® develops, markets, and sells more than 25 products in support of a healthy lifestyle. The product line includes nutraceutical powder mixes, supplements, and chews sold through mass, food, and drug retailers.
Cardium is working to broaden and grow its To Go Brands® nutraceutical supplement brand platform and continues to review acquisitions of other companies and businesses to identify additional product opportunities and technologies.
For more information, visit www.cardiumthx.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Company CEO Christopher J. Reinhard founded the company in December 2003, backed by nearly 15 years of focus on the commercial development of cardiovascular growth factor therapeutics.
Under Reinhard’s leadership, Cardium is working to advance its ASPIRE Generx® clinical study at major medical centers in Russia. The company is also seeking clinical development and commercialization partners for Generx® in countries such as India, China and Brazil.
The Generx® product candidate is a minimally invasive DNA-based angiogenic growth factor therapy in development for the treatment of patients with advanced coronary artery disease. The product is being developed for international markets as an alternative treatment for patients who may not have access to surgical revascularization procedures such as coronary artery bypass surgery and angioplasty/stents.
Cardium’s Excellagen® is a syringe-based collagen gel designed to speed the growth of granulation tissue and to trigger the wound healing process. The product is FDA-cleared as treatment of neuropathic and diabetic foot ulcers, pressure ulcers, venous ulcers, surgical wounds, and other dermal wounds. Cardium is seeking commercialization partners for the marketing and sale of the product both domestically and internationally.
Cardium’s To Go Brands® develops, markets, and sells more than 25 products in support of a healthy lifestyle. The product line includes nutraceutical powder mixes, supplements, and chews sold through mass, food, and drug retailers.
Cardium is working to broaden and grow its To Go Brands® nutraceutical supplement brand platform and continues to review acquisitions of other companies and businesses to identify additional product opportunities and technologies.
For more information, visit www.cardiumthx.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
StreamTrack, Inc. (STTK) Subsidiary Signs Agreement to Add Over 3,000 Stations
Today before the opening bell, StreamTrack announced that its subsidiary, StreamTrack Media, Inc., has entered into a two-year licensing agreement with RadioReference, LLC.
RadioReference has agreed to utilize the RadioLoyalty Platform™ for radio broadcast monetization of numerous licensed stations. SreamTrack anticipates completing the integration by July 15, 2013. The addition will increase RadioLoyalty Platform’s total count to approximately 5,000 stations.
The world’s largest radio communications data provider, RadioReference features a complete frequency database, trunked radio system information, and FCC license data. The company is also recognized as the largest broadcaster of public safety live audio communications feeds, hosting thousands of live audio broadcasts of Police, Fire, EMS, Railroad, and aircraft communications.
“At the time of this announcement, RadioReference has 3,494 stations that StreamTrack is working to integrate,” StreamTrack’s Chief Executive Officer, Michael Hill, stated. “Under the terms of the license, StreamTrack Media will record 100% of the advertising revenue generated through the RadioLoyalty Platform™ for all 3,494 stations. RadioReference will be paid a flat monthly content fee by StreamTrack Media for supplying the content from the stations. RadioReference will supply unlimited listener caps and bandwidth to support the listening through the RadioLoyalty Platform™.”
For more information, visit www.StreamTrack.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
RadioReference has agreed to utilize the RadioLoyalty Platform™ for radio broadcast monetization of numerous licensed stations. SreamTrack anticipates completing the integration by July 15, 2013. The addition will increase RadioLoyalty Platform’s total count to approximately 5,000 stations.
The world’s largest radio communications data provider, RadioReference features a complete frequency database, trunked radio system information, and FCC license data. The company is also recognized as the largest broadcaster of public safety live audio communications feeds, hosting thousands of live audio broadcasts of Police, Fire, EMS, Railroad, and aircraft communications.
“At the time of this announcement, RadioReference has 3,494 stations that StreamTrack is working to integrate,” StreamTrack’s Chief Executive Officer, Michael Hill, stated. “Under the terms of the license, StreamTrack Media will record 100% of the advertising revenue generated through the RadioLoyalty Platform™ for all 3,494 stations. RadioReference will be paid a flat monthly content fee by StreamTrack Media for supplying the content from the stations. RadioReference will supply unlimited listener caps and bandwidth to support the listening through the RadioLoyalty Platform™.”
For more information, visit www.StreamTrack.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Posts (Atom)
